Application of FTIR imaging and spectroscopy to solid dosage formulations. by Muthudoss, Prakash.
Application of FTIR imaging and spectroscopy to solid 
dosage formulations.
MUTHUDOSS, Prakash.
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/20107/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
MUTHUDOSS, Prakash. (2011). Application of FTIR imaging and spectroscopy to 
solid dosage formulations. Doctoral, Sheffield Hallam University (United Kingdom).. 
Copyright and re-use policy
See http://shura.shu.ac.uk/information.html
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
Adsetts Centre, City Campus 
Sheffield S1 1WD
1 0 2  0 0 1  82 4  0
REFERENCE
ProQuest Number: 10697414
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com ple te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10697414
Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
Application of FTIR Imaging and 
Spectroscopy to Solid Dosage Formulations
Prakash Muthudoss
A thesis submitted in partial fulfilment of the requirements of 
Sheffield Hallam University 
for the degree of Doctor of Philosophy
April 2011
Collaborating Organisation: AstraZeneca, Macclesfield, 
United Kingdom
ABSTRACT
The preparation of solid dispersions, in this study felodipine/poly vinyl pyrrolidone solid 
dispersion, is a multifaceted phenomenon. In order to understand the formation of solid 
dispersions two different mixed solvent system, three different temperatures and 
different drug loadings were selected and monitored in real time using Attenuated Total 
Reflectance- Fourier Transform Infrared Spectroscopy. 50 pi of the prepared solution 
was placed onto a pre-heated ATR crystal. The effect of PVP/API ratio, molecular 
interactions and effect of temperature (30°C, 40°C and 50°C) on the rate of film 
formation (solid dispersions) was evaluated. The changes in the peak positions, peak 
intensities and peak width as a function of time was monitored. The data were then 
analysed using peak height measurements, statistical and chemometric data analytical 
tools. It was shown that the nature of the solvent, the working temperature, presence of 
polymer and low drug loading was found to influence the rate of evaporation of solvent, 
molecular interactions and quality of the final product. Moreover, using 
thermogravimetric techniques it was complemented that the residual solvent within the 
systems was within the studied limits.
The spatial arrangement or distribution of components within solid dispersion was 
found to influence the physical stability, phase behaviour, dissolution and 
bioavailability. Mid infrared spectroscopic imaging has been shown to be useful and has 
provided unique insights in to various fields. However, it has very limited applications 
in analysing the pharmaceutical materials. This work aims to evaluate various image 
processing tools in extracting process related information. Three model systems with 
varying chemical composition were selected. The chemical images from the regions of 
interest were collected using a Varian 620 FTIR Imaging instrument equipped with 64 x 
64 MCT-Focal Plane Array (FPA) detector. Firstly we showed the impact of optical 
artefacts on the quality of the acquired image. The data was then pre-processed to 
remove baseline effects, pathlength variations and image processed to extract 
distribution maps. Agreement between the data generated using peak height 
measurements, compare correlation, principal component analysis and multivariate 
curve resolution was obtained only with the simple systems, the advantage with the 
latter being that the supervised and unsupervised chemometric approaches do not 
require any prior information about the sample and does not suffer from any physical or 
chemical interferences. The success o f MCR-ALS over compare correlation and PCA 
methods is that it does not require any pure materials library and provides chemical 
information respectively. Moreover, implementation and data extraction is easy using 
MCR-ALS. It was then showed that once the optical artefacts are separated and 
chemically significant information is extracted, the benefits of infrared imaging was 
multitude.
The optimised procedures were then applied to other samples to expand the applications 
of mid infrared imaging. There is no established paper to date describing the application 
of FTIR imaging to study the solvent induced phase separation in solid dispersions. One 
of the aims of this work is to study the impact of two different solvents on the phase 
behaviour of felodipine/polyvinyl pyrrolidone solid dispersions cast from different 
binary solvent systems. The temperature induced phase separation and degradation have 
been studied using differential scanning calorimetry, scanning electron microscopy, 
thermogravimetric etc, however we have shown the application of FTIR imaging in 
assessing the temperature induced degradation complemented and supported by in situ 
ATR-FTIR spectroscopy and thermogravimetric analysis.
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C h a p t e r  1. 
B a c k g r o u n d  a n d  In t r o d u c t io n
1.1 Pharmaceutical Substances
A pharmaceutical substance or active pharmaceutical ingredient (API) or drug is a 
compound that is intended to furnish pharmacological activity or other direct effect in 
the diagnosis, cure, mitigation, treatment or prevention of a disease or to affect the 
structure of any function of the human body.1 However, these pharmaceutical 
substances do not include any intermediates used in the synthesis. Drug development is
a tedious, expensive and a time-consuming process and the time frame for drug
1 2development from screening to market launch on average requires 10-12 years. 5 
Various stages from discovery to marketing are, drug discovery, drug development, 
clinical trials, manufacturing procedures, marketing approval.1
Drugs are hardly ever administered as pure chemical substances, instead formulated in 
combination with one or more non-medicinal agents or excipients.3 These formulations 
are termed dosage forms. An active ingredient can be formulated into a variety of 
dosage forms. The dosage forms are classified based upon the routes of administration 
like Oral, Rectal, Topical, Parenteral, Nasal, Eye, Ear, etc. The preferred route for 
administering drugs is through mouth or commonly termed as oral route of 
administration. Solid oral dosage forms are more stable, easy to produce and more or 
less accurately delivered than the other oral dosage forms like suspensions, emulsions, 
syrup etc. However, formulating a successful dosage form requires consideration of 
physical, chemical and biological characteristics of ingredients and excipients used in 
fabricating the product.3,4
1.2 Aqueous solubility, dissolution rate and bioavailability
When the dosage form is administered, the aqueous soluble drugs are dissolved or 
solubilised either in the stomach or small intestine through the action of gastro-intestinal 
(GI) fluids (dissolution) and transported to the blood or systemic circulation.5 The 
amount of drug required to reach the systemic circulation determines the physiological 
action and is termed as bioavailability.5’6
New drug molecules with poor aqueous solubility have risen sharply7 and compounds 
having solubility as low as less than 1 pg/ml are reported.6 Due to poor aqueous 
solubility, the available GI volume will not be able to dissolve the required dose o f drug 
directly affecting the bioavailability. Dissolution may be the rate limiting step for such
hydrophobic drugs.8 The problem of delivering poorly water soluble active 
pharmaceutical ingredients (APIs, or "drugs") is one that is increasingly taxing the 
pharmaceutical scientists. The first and foremost focus during drug development is 
enhancing the bioavailability of hydrophobic drugs.9' 11
The relationship between solubility and dissolution is well understood using the 
modified Noyes-Whitney equation which is
d U  AD(Cs ~Ct)_  _ w
d t  h w
where dM/dt is the dissolution rate; A is the specific surface area; D  is the diffusion co­
efficient; h is the diffusion layer thickness, Cs is the saturation solubility and Q  is the 
drug concentration at time t.
The diffusion coefficient and diffusion layer thickness are physiological parameters 
which are often difficult to be manipulated.5 However, improving the solubility through 
formulation approaches is the most attractive option.7,10 Tailoring the surface area and 
manipulation of saturation solubility are some of the available approaches to improve 
aqueous solubility. The available surface area for dissolution can be increased by 
reducing the particle size (e.g. milling, micronisation).5,7,12 The saturation solubility can 
be altered by chemically modifying the pharmaceutical substances (e.g. salts) or 
changing the physical state of the drug in the formulation (e.g. metastable polymorphs, 
amorphous form).7,13
1.3 Amorphous systems and Solid Dispersions
A crystalline substance melts at a certain temperature which is the melting temperature 
(Tm)  and rapid cooling of this melt yields supercooled liquid. Further cooling produces 
glassy material: the temperature at which this transition occurs is termed as the glass 
transition temperature.14,15 The property of materials at Tm, below and above Tg vary 
significantly.
The amorphous phases or forms of pharmaceutical active substances have received
greater attention.15 This is due to the fact that amorphous forms contain higher free
16 18energy which helps to attain higher dissolution rate and hence better bioavailability.
The solubility advantage of factors approximately >1000 for amorphous 
pharmaceuticals over crystalline forms has been predicted.16 The incorporation of 
polymeric stabilisers to the amorphous form and presenting the drug as a molecular 
dispersion, also called solid dispersion, offers a multitude o f functional advantages.
With solid dispersions, there are improvements in bioavailability because there is 
reduction in particle size, improved wettability, higher porosity and change in drug 
crystallinity.7,10’19'21 Moreover, aforementioned improvements are the parameters 
concerning the surface area and saturation solubility with the Noyes-Whitney solubility 
relationship.5
Solid dispersion refers to solid state mixtures, prepared through the dispersion, typically 
by solvent evaporation or melting (fusion) or melting-solvent methods, of one or more
11 Oft 00active ingredients in an inert carrier matrix. ’ ’ It also refers to a product formed by
13 9 1 9 3converting a fluid-carrier combination to the solid state. ’ ’
When the technique was first introduced it was believed that the drug was in a 
microcrystalline state in the drug/polymer mixture with the formation of eutectic 
systems24 and was later termed as “solid dispersion”.20 Conversely, it was suggested 
that some of the drug particles might be molecularly dispersed (solid solution) or drug 
being present as small particles embedded (solid suspension) in the polymeric 
matrix.25,26 Nevertheless, the fundamental principle remains the same, that is, the drug 
particles are released as fine particles upon exposure to aqueous media when the carrier 
component o f the solid dispersion dissolves.
As already mentioned, the amorphous forms have higher solubility than the crystalline 
counter-parts. To quantify the benefits, the thermodynamic or thermal properties have 
been used to compare the predicted and experimental solubility. Hancock and Parks16 
using a simple thermodynamic approach (based on the free energy difference between 
two physical forms) reported a procedure for the estimation o f solubility advantage. 
However, the predicted and experimental solubility was in close agreement only with 
crystalline materials. Pikal and co-workers17,18 proposed a modified procedure for the 
estimation of amorphous solubility, yet the procedure was successful only for 
amorphous systems that were slowly crystallising from the aqueous media. For rapid 
crystallising materials there are more limitations. Nevertheless, the number o f marketed 
products developed using the solid dispersion approach is very limited10,13 whilst there 
have been many publications concluding increased dissolution rates. This could be
27attributed to the lack of basic understanding of these systems at the molecular level.
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1.4 Solid Dispersion and Potential Characteristics
1.4.1 Choice o f manufacturing process
Various approaches used in the generation of solid dispersions are the melt or fusion 
method,10 the solvent method,13 melting-solvent method,20 etc. If the carrier selected has 
a lower glass transition temperature (Tg), as with PVP and felodipine the preferred 
choice is the solvent method. The drug and the polymer are mixed in a common solvent 
upon removal of the solvent, solid dispersions are obtained.5,10 Since the solvent 
evaporation occurs at ambient or room temperature, this method is suitable for 
processing thermolabile compounds.6,7 Practical or industrial applications of pilot scale 
solvent evaporation method are spray drying and freeze drying. However, finding a 
common solvent is not easy; toxicity or physical instabilities of residual solvents and 
high manufacturing cost are some of the limitations of the solvent method. The choice 
of preparation method (Spray drying or melting) influenced morphology or particle size 
of triamterene-D-mannitol solid dispersions and the dissolution rate.
1.4.2 Solvent selection
In the solvent method, the solubility of drug and the polymer in the solvent is a 
prerequisite to obtain stable solid dispersions. The physical state of the prepared 
dispersions is influenced by the drug-to-solvent and/or carrier-to-solvent ratio, solvent- 
solid interactions, temperature of drying, evaporation rate and the nature of the solvent.
10,30 Solvent nature, Gutmann’s acceptor-donor number and density are some of the
factors that are important while selecting the solvents. Spectroscopic studies have
31 •shown that solvents can alter molecular interactions of 1,4 dihydropyridine, swelling 
behaviour of hydrogels,32 change in the conformation,33 alter the denaturation of 
urea34,35 etc. These effects are characterised by solvent induced frequency shifts31 
(SIFS) in carbonyl moieties and other groups involved in the intermolecular 
interactions. In contrary, self-association and solvent-solvent interactions can decrease 
the maximum solubility of the drug.
1.4.3 Importance o f Molecular interactions
Various interactions known to-date37 are H-bonding, ion-dipole, dipole-dipole, 
complexation and Vander Waal’s interactions or combinations of the aforementioned 
interactions.38 Likewise electrostatic interactions between the drug and the polymer are 
reported.39 The physico-chemical properties of the drugs are altered due to the presence 
of strong heteromolecular interactions like hydrogen bonds.11 In addition, these 
interactions have a pronounced effect on the molecular state of the drug.40 Applications
4
include improvement of the solubility of hydrophobic drugs, enhanced dissolution rates, 
increased drug release rate, improved stability, enhanced bioavailability, altered 
therapeutic activity and reduced side effects.37 Interestingly, Timmins et al.,38 showed 
that drug-polymer interactions could reduce crystallinity even if the products are 
physically mixed.38
1.4.4 Understanding dissolution behaviour or drug release
Compared to the crystalline form, the amorphous systems require no additional energy 
to dissolve in the gastro-intestinal enzymes or fluids. Additionally, the advantage of 
solid dispersions over amorphous forms in enhancing the release of drug and dissolution 
rate of the drug is enormous.41'43 Water soluble polymers together with biological 
factors like bile acids and fatty acids solubilise the dissolved drug and hence facilitate 
the dissolution rate.
1.5 Implications of knowing these characteristics
Several experiments have been conducted in the past few years to understand the 
stability o f amorphous pharmaceutical formulations. These can be illustrated by 
considering the solution state stability and solid state stability separately. The solid state 
stability concerns with the manufacturing and storage aspects; while the solution state 
stability mainly concerns with drug release and dissolution rate in the stomach or small 
intestine.
To understand the recrystallization process or solid-state stability of solid dispersions, 
evaluation of kinetic and thermodynamic factors is quite important.30,44 From a kinetic 
point of view, molecular mobility is a key factor that is frequently reported detrimental 
when assessing the stability of amorphous forms. In a thermodynamic perspective, 
solid-solid or drug-polymer miscibility is a prerequisite to retard the amorphous- 
amorphous phase separation and hence improve the physical stability of solid 
dispersions. The recrystallization process in the solution state always starts by a 
nucleation event followed by crystal growth.5
To overcome these undesirable events, various formulation strategies were developed. 
Addition of polymers reduces the molecular mobility either by increasing the viscosity 
of the mixture (antiplasticization effect) or through specific drug-polymer molecular 
interactions.27,45,46 Manipulating the drug-polymer interactions not only facilitates 
thermodynamic solid-solid miscibility or drug dissolution rate but does provide the 
opportunity in designing optimally stabilized amorphous systems 47 Taylor et al.,4S
5
investigated physical stability of model hydrophobic drug-PVP solid dispersions upon 
exposure to high relative humidities. It was shown that model drugs with NH moieties 
underwent moisture-induced drug-polymer immiscibility while model drugs with 
GOOH moieties were miscible. The physical stability was influenced by solid-solid or 
drug-polymer miscibility. It was showed that the hydrophobic-drug polymer systems 
which were partially miscible were more prone to phase separation and subsequent 
recrystallization than systems which showed complete miscibility.48'50
From the biopharmaceutical point of view, the selected polymer should solubilize the 
drug, molecularly interact and reduce the nucleation rate. Additionally, the kinetics o f 
drug release from the solid dispersion depends on the dissolution mechanism like 
wetting or dispersability and an extensive knowledge of this would help in formulating 
better process conditions.13,47 For dissolution enhancement, Telang et al., prepared 
ternary dispersions of indomethacin (IMC) by incorporating the surfactant meglumine 
(MU) in the polymer polyvinyl pyrrolidone (PVP) in an attempt to prevent 
crystallization from the supersaturated solutions. The prepared ternary dispersion 
showed improved physical stability and enhanced dissolution rate.51
Moreover, Vanden Mooter et al.,52 showed that sprayed dried itraconazole/eudragit 
E l00 solid dispersions were superior in product performance to the melted products and 
concluded that the influence of drying kinetics on phase behaviour or solid-solid 
miscibility has to be understood. Patel et al., formulated solid dispersions of two poorly 
soluble anti-cancer drugs (CurcurbitacinB and CurcurbitacinI) using PEO-b-PCL 
diblock polymer.53 At low levels of PCL there was increased solubility; however 
increasing the content decreased the dissolution rate due to retardation o f drug release 
from the polymer matrix. That is, the degree and nature of molecular interaction can 
affect the dissolution and bioavailability.42,54,39,53,55 Moreover, the addition of 
surfactants could increase the nucleation rate and hence decrease the solution stability.5
Poor prediction still persists in understanding the importance o f these individual 
characteristics. The challenges concerning the basic understanding could be due to poor 
predictability of the properties of the resultant material, influence of manufacturing 
conditions or factors governing stability considerations. Major difficulties for this 
knowledge gap have most certainly been the limitation of characterisation techniques to 
study the solid-state and the solution-state stability and the interplaying factors on a 
molecular level. Understanding the potential characteristics involved in the formulation
6
of solid dispersions will be a good starting point to design an effective characterisation 
protocol as shown in Figure 1.1.
A wide range of analytical methods have been used to study the prepared solid 
dispersions with the aim to understand the structure of solid dispersions, the 
crystallization kinetics, drug-polymer-excipient interactions, molecular mobility and 
thermodynamics of the molecular state.47 The advantages o f using infrared (bulk 
spectroscopy and spectroscopic imaging) and complementary techniques to improve the 
understanding of the distribution of each component within the polymer matrix, the 
dynamics of solid dispersion formation and the physical stability of solid dispersions 
will be discussed in the following chapters.
1.6 Aims and Objectives
The objective of this project was to investigate the applicability of mid-infrared 
spectroscopy and spectroscopic imaging techniques to characterise the drying kinetics, 
molecular interactions, phase separation, phase transition and homogeneity or 
heterogeneity in distribution. In this context, the aim of this research was to develop 
methodologies and experimental toolbox involving mid infrared spectroscopy to 
effectively characterise the solid state stability of solid dispersions.
Fourier Transform Infrared Imaging (FTIR-Chemical Imaging) allows us a new 
dimension to probe the distribution of the components on the micron scale. However, it 
has also raised particular challenges in extracting useful information from the chemical 
images. In this direction, particular attention will be paid to the evaluation and 
optimisation of experimental design and of procedures to provide statistical and 
chemometric data analysis schemes.
In order to achieve our motivation model drug (felodipine), model polymer 
(polyvinylpyrrolidone, PVP) and various solvents (acetone, methanol and 
dichloromethane) were included in the study. These model systems were selected 
because extensive work has been carried out among different groups across the globe to 
prepare, characterise and study the stability of felodipine/PVP solid dispersions. 
Moreover, these model systems are widely used in the pharmaceutical industry.
Since there is no exploration to date in describing the formation of solid dispersions, 
one of the main objectives of this research is the application o f vibrational spectroscopy 
to understand the dynamics involved in solid dispersion formation. The effect of 
temperature, solvent, polymer and drug loading will be studied in detail. Furthermore,
the residual solvents present within these systems were studied by applying 
thermogravimetric measurements. Once the formation of solid dispersions and image 
processing tools are established, the influence of solvents on phase behaviour, moisture 
induced phase transition and temperature induced chemical decomposition/degradation 
of the selected systems will be studied in depth.
Poorly soluble drugs
Solubility Enhancement Approaches
Stability
Solid dispersions
Solid State Stability Solution State Stability
Kinetic factors
- Molecular Mobility 
Thermodynamic factors
- Glass transition
- Phase separation
Formulation
Compounds
Formulation Strategies
- Preparation method
- Molecular interactions
- Antiplasticization
\
Solid state 
characterisation
Formulation
Compounds
Formulation Strategies
- Wettability
- Molecular interactions
- Retardation o f  nucleation
Solution State 
characterisation
Figure 1.1. Understanding the potential characteristics involved in the formulation of 
solid dispersions as a starting point to design an effective characterisation protocol.
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C h a p t e r  2. 
F e l o d ip in e /p o l y v in y l p y r r o l id o n e  So l id  D is p e r s io n s
2.1 Model Polymer-Polyvinylpyrrolidone (PVP)
Polyvinylpyrrolidone (PVP) is made from the monomer N-vinyl pyrrolidone. PVP has 
hydrophilic and hydrophobic groups which makes it soluble in water and various other 
solvents.57,58 The relative molecular mass of PVP ranges from 2500 to 1 million and 
PVP of lower relative molecular mass are used in pharmaceutical industries.56 PVP 
grades are distinguished by their K-value, a measure of specific viscosity and this 
correlates with the molecular weight.56
Chemical Structure of Polyvinylpyrrolidone (p yp )56,59,60.
PVP forms a molecular adduct solubilising the insoluble substances;7 thus PVP is one of 
the common carriers used in preparing solid dispersions.6,61 Due to the steric hindrance, 
the lone pair of electrons on nitrogen atom doesn’t involve in the intermolecular 
interactions, while the involvement of the C=0 group is favoured.62 Precisely, PVP 
stabilises the solid dispersions through intermolecular interactions with proton donating 
drugs,22,62 ion-dipole interactions with proton accepting drugs63 and the antiplasticing 
effect with neutral drugs.30
In addition, PVP polymers are used as crystal growth inhibitors and/or rheological 
additives in soft gelatine capsules, oral liquids and suspensions, parenteral formulations, 
topical gels creams, lotions and ophthalmic preparations.
2.2 Model Drug-Felodipine
Felodipine is a dihydropyridine derivative that is chemically described as ethyl methyl- 
4-(2, 3-dichIorophenyl)-l, 4-dihydro-2,6- dimethyl-3, 5-pyridine-dicarboxylate,64,65 a 
calcium channel blocker, widely used in the treatment of angina pectoris and 
hypertension.66'68 It acts by relaxing the vascular smooth muscle. In addition, felodipine 
when administered dilates the coronary and peripheral arteries.
Felodipine shows polymorphism69 and chirality68 unlike other 1, 4 dihydro pyridine
derivatives. The different crystal forms and the properties are given in the Table 2.1.
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Partial decomposition is found in the annealed and molten form but not in the
1TQcommercially available products.
. c o o c h 2c h 3
£€> »7AChemical structure of Felodipine
Felodipine is very poorly soluble in water and the aqueous solubility at ambient 
temperature is determined to be 0.5 mg/1.69 Srcic et al.,31 studied the molecular 
interactions of 1,4 dihydro pyridine (DHP) derivatives like nifedipine, nitrendipine, 
nimodipine and amlodipine in different organic solvents. For uncharged molecules there 
was good correlation between the acceptor-donor number and the carbonyl stretching 
vibrations of the derivatives. The DHP’s act as H-bond donors in solvents with low 
acceptor number (AN) whereas they are strong H-bond acceptors in solvents with high 
AN. However, in protic solvents like ethanol/methanol, the DHP’s can act as H-bond 
donors and acceptors.
These properties affect the dissolution rate of felodipine, if it is formulated as a 
conventional dosage form.65 Several approaches to increase the dissolution rate of 
felodipine have been undertaken.71'74 The formation of a glassy phase by producing 
amorphous felodipine is one such method.65 Amorphous felodipine is prepared either by 
cooling the melt at room temperatures or by quenching under liquid nitrogen and has a 
glass transition temperature (Tg) of 43 °C. Velaga et al.,15 obtained felodipine form II 
reproducibly by co-crystallising with isonicotinamide. The results were confirmed 
through the appearance of the NH stretching peak at 3336 cm '1 and carbonyl peaks at 
1698 and 1683 cm'1.
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Table 2.1. Data of (±)- and (+)- Felodipine crystal forms'
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Chamarthy and Pinal12 milled felodipine crystals to induce crystal disorder. A high 
degree of crystal disorder can introduce amorphous character; however, milling 
felodipine material induced crystal defects but not amorphous character. Lindfors and
7  ft  •co-workers showed that even the amorphous felodipine nanoparticles were sensitive to 
very small amounts o f crystalline material in seeding experiments. However, the 
prepared metastable states can revert to the more thermodynamically stable crystalline 
polymorph. Hancock and co-workers15 showed that amorphous compounds above and 
just below their Tg experience molecular mobility which is one of the factors 
responsible for the physical instability. However, utilization of different polymers to 
inhibit the crystallization39 and improve the release kinetics have been proposed.47 
When high Tg polymeric materials are added to the crystalline drugs, the Tg of the 
resulting amorphous solid dispersions is increased thereby reducing the molecular 
mobility of the high energy states consequently inhibiting the crystallization.
2.3 Felodipine/PVP Solid Dispersions
Hwang et al.,77 studied the influence of preparation method (rotary evaporation or 
conventional solvent method and supercritical fluid anti-solvent precipitation) on the 
physicochemical characteristics of felodipine/hydroxylpropylmethylcellulose (HPMC) 
solid dispersions. The mean particle size of felodipine was 200-250 nm with 
supercritical fluid anti-solvent precipitation but was found to be irregular with voids 
when prepared using conventional solvent method. These properties did influence the 
dissolution rate to a marked extent and the authors concluded that the supercritical fluid 
anti-solvent precipitation method of preparation was far superior to the conventional 
methods. An alternative method to solvent evaporation and melting was the microwave 
irradiation wherein the model drug felodipine along with the polymer was placed in a 
beaker in the microwave chamberl.74 The microwave energy was used as a source of 
heat to transform the crystalline material to amorphous, instead of the conventional 
melting method.74,78 Many studies have been focussed upon the novel methods for 
preparing the amorphous forms; however, physical instability has been the major hurdle 
for solid dispersion techniques to reach the market.
Bhugra e t«/.,79,80 showed that a simple correlation does not exist between the molecular 
mobility and crystallization tendency. Zografi and co-workers81 in a series of studies has 
shown that even at low levels of polymeric materials the crystallization was inhibited. 
Neither molecular weight nor Tg of polymer had influence on the crystallization 
inhibition. Using spectroscopic studies these improvements were related to the
13
intermolecular interaction between the drug and the polymer. In another study, Aso and 
Yoshioka showed that molecular interactions were responsible for the nifedipine and 
phenobarbital-PVP amorphous solid dispersion having reduced molecular mobility and 
hence its physical stability. In felodipine, the polar groups C=0, Cl and NH are 
involved in the intermolecular interactions. With lipophilic excipients both C=0 and
48NH interact while with hydrophilic excipients only the NH group is involved . 
Moreover, researchers41,54 studied the effect of particle morphology, physical state of 
the drug, particle size distribution and the drug polymer interactions on the felodipine 
dissolution mechanism.
The intermolecular interaction between the drug and the polymer differentiates the 
physicochemical properties of the pure drug molecules. Karavas et al.,n and Bikiaris et 
a/.,22 studied the potential effects of H-bonding interactions on solubility, dissolution 
profile and contact angle. It was established that the interactions reduce the particle size 
and enhance the solubility of felodipine thereby improving the dissolution rate. The 
contact angle measurements suggested that the hydrophilicity of the polymer did not 
significantly influence the dissolution rate. Moreover, at low drug concentrations (10% 
w/w) the release of felodipine from PVP was diffusion controlled and at high drug
9 9  9 3  83concentrations the release was dissolution controlled. ’ ’
Vasanthavada et al.,84 showed that intermolecular interactions favour the solid solubility 
of drug in the polymer. The solid solubility was found to influence the physical 
stabilisation, that is, of the two models studied, drugs indoprofen interacts with PVP 
while griseofulvin does not. The interacting system was physically stable but Gris-PVP 
was phase separated.
Ktistis et al.,85 showed that although there is strong interaction of felodipine with PVP, 
these systems are only partially miscible. Interestingly, this interaction is sufficient to 
reduce the particle size to the nanoscale which was found to influence the dissolution 
rate but this reduction is dependent upon drug-polymer ratio.
Sigalas and Teberekidis86 showed based on quantum mechanical modelling and 
computational studies, that felodipine forms stronger hydrogen bonds with PVP than 
polyethylene glycol (PEG).
Kestur et al.,87 studied the effect of molecular weight and viscosity on the crystallisation 
kinetics of felodipine/PVP solid dispersions. Intermolecular interaction between the 
drug and the polymer (PVP) was not dependant on the molecular weight or different
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grades of the polymer. The results indicate that molecular weight and viscosity have 
limited effects on the molecular mobility and thence the recrystallization of amorphous 
solid dispersions. Moreover the inhibition of crystal growth rate is due to reduced 
molecular mobility and hence it is a kinetic rather than thermodynamic one, through the 
formation of drug-polymer interactions.
Marsac et al.,88 studied the effect of temperature and moisture on the miscibility of 
felodipine/PVP amorphous solid dispersion’s and amorphous felodipine. The NH 
stretching peak in crystalline felodipine is centred at 3372 cm '1 while in the amorphous 
felodipine due to drug-drug interactions the peak is centred at 3341 cm '1 and in solid 
dispersion’s this peak is centred at 3290 cm"1. All compositions of felodipine/PVP are 
miscible at room temperature as suggested by the presence of drug/polymer interactions, 
the value of Tg and modelling studies.88,89 When the amorphous polymer was heated 
from 5 °C to 160 °C the NH peak centred at 3337 cm '1 shifted to 3350 cm'1, which is 
indicative of a weakening of the intermolecular interactions. This shift was found to 
occur close to the Tg of the studied system. However, these effects were reversible. 
When felodipine/PVP ASD’s was exposed to high relative humidity (atmospheric 
moisture or liquid water) >75% there was irreversible disruption of drug/polymer 
interactions and there was amorphous-amorphous phase separation. In contrast, long 
exposures induced crystallisation. This study shows that drug/polymer combinations are 
susceptible to moisture induced immiscibility.
Rumondor et al.,48 studied the influence of different degrees of moisture (54%, 75%, 
84% and 94%) and compared the phase behaviour of four model systems consisting of 
nifedipine, droperidol, ketoprofen, indomethacin and pimozide. Drug-polymer 
interactions provide information on the intimacy of mixing and hence the solid-solid 
miscibility. Any disruption of these interactions at the expense o f drug-drug interactions 
is indicative of amorphous-amorphous phase separation. The results of this study 
indicated that the crystallisation could happen either directly from the miscible 
dispersions or through amorphous-amorphous phase separation. The latter route was 
found to impose faster crystallisation as the polymer inhibitory effect is reduced. 
Moreover, the NH moieties were sensitive to moisture induced immiscibility while 
model systems with COOH moieties were less susceptible. The other factors that were 
found as co-influences were strength of drug water interactions and total moisture 
absorbed by the system.
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Rumondor et al.,90 studied the impact of moisture and polymer type (PVP and 
HPMCAS) on the physical stability of felodipine/PVP amorphous solid dispersion’s. In 
the absence of moisture both the polymers were crystallisation inhibitors. When the 
RH>75% HPMCAS was a better polymer than PVP in inhibiting the crystallisation. 
However the system firstly undergoes amorphous-amorphous phase separation followed 
by crystallisation.
Rumondor et al.,91 studied the influence of different degrees of moisture (13% to 80%) 
of felodipine solid dispersions prepared from PVP and HPMCAS. The researchers 
showed that for <64% moisture PVP was a better polymer but for >64% HPMCAS was 
better because there was moisture-induced drug-polymer phase separation.
Ivanisevic49 studied the physical stability of twelve model amorphous solid dispersion’s 
(consisting two polymers PVP, PAA and four drugs felodipine, ketoprofen, nifedipine 
and indomethacin) for the period of nine to twenty-two months. The systems initially 
determined to be miscible were amorphous (as determined by XRD) for the entire 
length of the study. The initially phase separated systems crystallised within one or two 
months while amorphous systems (in the absence of polymers) crystallised within days. 
The conclusion of the study was that good physically stable dispersions were obtained 
with good drug polymer miscibility.
Eerdenbrugh, Baird and Taylor92,93 investigated 51 model compounds and evaluated 
their crystallisation tendency. These compounds were prepared using melting and rapid 
solvent evaporation methods. The crystallisation tendency of the model compounds 
from the melt was based upon molecular weight, structure and orientation of the 
molecules. These physicochemical properties were also descriptors of the model 
compounds glass forming ability (GFA) and in producing stable amorphous/glass (glass 
stability, GS) compounds. The results indicated clear differences in the crystallisation 
behaviour. Based upon the crystallisation tendency, a “crystallisation classification 
system” was developed and the compounds were described as being class I (rapid 
crystallizers or crystallization immediately after spin coating), class II (intermediate 
crystallizers or crystallization within 7 days of storage) or class III (slow crystallizers or 
no signs o f crystallization even after 7 days of storage). Moreover, the results suggested 
that class I compounds were not ideal condidates to be adapted for the solid dispersion 
technology.93
With the aforementioned understanding about the pure amorphous compounds,
Eerdenbrugh and Taylor46 investigated the ability of 7 chemically diverse polymers to
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inhibit the crystallisation of class I and class II model drugs from amorphous solid 
dispersions. The results of this investigation showed that acidic polymers were better 
crystallisation inhibitors for neutral and basic model compounds. Hence there is no 
superior polymer universally better than the others but a rationale for good selection can 
be based on the drug-polymer chemistry.
Konno et al.,72 demonstrated the importance of solid state and solution state stability by 
preparing felodipine amorphous solid dispersions (ASD’s) with different polymers 
(PVP, HPMC and HPMCAS). This study was carried out to understand the inhibition of 
recrystallization of the amorphous form from the supersaturated dissolution medium. Of 
the studied polymers, HPMCAS was not only found to produce higher amounts of 
supersaturated solution but was superior at inhibiting the crystal growth rates compared 
to PVP or HPMC. This study shows the importance of reconsidering the suitability of 
polymers to show good solid and solution state stability.
Taylor et al.,94 studied the dissolution behaviour of felodipine and indomethacin (IMC) 
solid dispersions prepared from three different polymers (PVP, HPMC and HPMCAS) 
at 25 °C and 37 °C. These two drugs were selected because they both had similar glass 
transition temperatures. The results of dissolution profile shows that supersatured 
solutions were formed for both the compounds upon dissolution at 25 °C but at 37 °C 
only IMC produced supersaturated solutions but not felodipine. These results implicate 
the complexity of dissolution behaviour (Tg is not the key factor).
Since much structural information and basic understanding is available in the literature 
about the felodipine/polyvinylpyrrolidone systems, this particular system will be carried 
further to survey the range of potential physical characterisation methods and data 
analytical approaches.
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C h a p t e r  3 
R e s e a r c h  D e s ig n  a n d  M e t h o d s
3.1 Preparation of Solid Dispersions
Various preparation methods for solid dispersions have been reported. O f the available 
approaches, preparation of solid dispersions involving solvents is most common6,7,10 
The first step in the solvent method is to mix the drug and the polymer in a common 
solvent. The second step involves the removal of solvent(s) which results in the 
formation of a solid dispersion. The other strategies are the use of binary solvent 
mixtures (BSM’s) which can be solvent-solvent (both drug and the polymer are soluble) 
or solvent-nonsolvent (drug is soluble in both the solvents but polymer is insoluble in 
one o f the solvent) mixtures. In this research, solvent casting and spray coating were the 
two pilot scale solvent methods used for the preparation of solid dispersions.
3.2 Characterization of Solid Dispersions
A wide range of analytical methods (shown in Table 3.1) are used to investigate the 
properties of the resulting amorphous solid state materials as a result o f employing the 
solid dispersion technique; with the aim to understand the mechanism, crystallization 
kinetics, drug-polymer interactions, molecular mobility and thermodynamics of the 
molecular state.47 The most frequently employed techniques to characterize solid 
dispersions are Fourier Transform-Infrared Spectroscopy, powder X-Ray diffraction, 
Differential Scanning Calorimetry, Scanning Electron Microscopy and Dissolution 
techniques. However, to tailor the research, various other techniques are combined, such 
as Transmission Electron Microscopy, Nuclear Magnetic Resonance, Thermally 
Stimulated Current, etc.21,95 Of the aforementioned techniques, FT-IR has been 
successfully applied to study the molecular structure, polymorphism, degree of 
crystallinity and molecular interactions in the solid dispersion systems.11,21,71 FT-IR will 
be applied to understand the real time film formation, to investigate drug-polymer 
interactions, spatial distribution, stability of solid dispersions employed in this research.
3.3 Fourier Transform Infrared Spectroscopy
3.3.1 Introduction
Infrared radiation is an electromagnetic radiation which is beyond the visible region of 
the spectrum or radiation not visible to the human eye.96 IR spectra provide information 
on the Vibrational and rotational changes within the molecules under study and this 
technique is also called vibrational spectroscopy.97 The infrared radiation is divided into
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three regions; near infrared (12800 -  4000 cm'1), mid infrared (4000 -  400 cm '1) and far 
infrared regions (400 -  20 cm'1).98
Table 3.1 Analytical techniques applied in the characterisation of
/» 7solid dispersions ’
Characterization Examples
Molecular interactions
Fourier Transform- Infrared Spectroscopy 
Nuclear Magnetic Resonance spectroscopy
Physical form UV-Vis spectroscopy
Thermodynamics
Raman spectroscopy
Thermogravimetric Analysis 
Differential Scanning Calorimetry
Physical form
Modulated DSC
Single crystal XRD  
Powdered XRD studies
Morphology
X- Ray scattering (small and wide angle)
Scanning Electron Microscopy 
Transmission Electron Microscopy
Distribution
Hot Stage Polarising Microscopy
Fourier Transform- Infrared Imaging systems
Morphology and Confocal and Global Raman Imaging
Molecular interactions Nuclear Magnetic Resonance Imaging
Release kinetics DissolutionMicroviscometry
3.3.2 Principle
Infrared spectroscopy is based on the fact that the molecular system should absorb 
electromagnetic radiation.97 For this to happen, one of the molecular vibrations should 
have the same frequency as the incident beam of light.96 The other specific feature is 
that, there should be a change in net dipole moment of the molecule during its 
vibration.99
3.3.3 Theory and Molecular Vibrations
In the context of vibrational spectroscopy, it is common to use, the wavenumber (v in 
cm'1); which is the number of waves per cm. It is given as;
where,
vis the frequency in hertz,
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C is the velocity of light (3 x 108m/s),
v  is the wavenumber in cm'1
X is the wavelength in cm.
58The advantage of using wavenumber is that, it is linear with the frequency or energy. ’ 
59 The relationship between frequency, energy and wavelength is given by Planck’s 
equation which is;
(2)
where,
E  is the energy,
h is the Planck’s constant (6.625 x 10'34 m2 kg s '1 or J s), 
v is the frequency,
C is the velocity of light 
If some energy is transferred from electromagnetic radiation by absorption, the 
amplitude o f vibrations is increased. In the simplistic harmonic model, the transitions 
can only occur between the adjacent levels, that is, u0tot) i, u i t0 ^ 2  and the energy 
associated with these levels are the same.100 If the energy of the radiation matching this 
difference is absorbed then the molecules are promoted from ground vibrational state to 
higher vibrational state which is given as;
AE =  Evl -  Evo (3)
Moreover,
AE =  hv or v  =  —h (4)
Substituting 3 in 4,
(5)
However, the frequency of vibration is related to the mass and the force constant and 
follows Hooke’s law which is;
(6)
where,
v is the vibrational frequency, 
k  is the classical force constant,
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H  is the reduced mass of the two atoms f-m- ™2- )Vnii+mz/
The simplistic harmonic model is best suited for diatomic molecules and for molecules 
that do not dissociate. For polyatomic and dissociating molecules a good approximation 
would be to consider the bond behaving as an anharmonic oscillator.101 If there are N  
numbers of atoms in the molecule, there will be 3N  degrees of freedom.97 The number 
of vibrations99 is described based on a three fold set of co-ordinate axes known as 
normal modes of vibration. Subtracting the translational and rotational motions of the 
molecule we get 3N-6 normal modes of vibration for non-linear molecule and 3N-5 for 
linear molecule.97 These vibrations can involve either stretching (change in bond length) 
or bending (change in bond angle). There are two types of stretching; symmetrical and 
antisymmetrical stretching and four types of bending vibrations which are rocking, 
scissoring, wagging and twisting.
3.3.4 Infrared Spectrum
An infrared spectrum is the plot of absorbance vs. wavenumber. A model infrared 
spectrum of felodipine is shown in Figure 3.1
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Figure 3.1. Model representation of infrared spectrum of felodipine 
3.3.5 Instrumentation
The significant development of FT-IR spectrometers began with the introduction of the 
Michelson interferometer (Figure 3.2) and, requires the Fourier transform mathematical 
procedure to convert the interference pattern to spectra generated by the 
interferometer.102 These developments outweighed the application of dispersive and
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grating IR spectrometers. FT-IR spectrometers employ Globar or Nernst sources in the 
mid-IR region and widely used detectors being DTGS (Deuterated Tri-Glycine Sulfate) 
in an alkyl halide window resistant to temperature changes and for more sensitive work 
the MCT (Mercury-Cadmium-Telluride) is used, however, it has to be cooled with 
liquid nitrogen.96
The radiation from the infrared source is directed on to a semi-reflecting beam-splitter 
made of germanium or iron-oxide coated onto a IR transparent material such as 
potassium bromide or caesium iodide.96 The beam splitter reflects approximately half 
the radiation to the moving and half to the fixed mirror.102 The beams then return to the 
beam splitter where they interfere and are partially reflected or transmitted again. The 
beam returning to the source is of rare interest while the beam travelling perpendicular 
to the input beam is measured.102 The two beams then recombine to produce an 
interference pattern, specific wavelengths within this beam will be constructive (in- 
phase) or destructive (out of phase) interfered depending on the path difference. At the 
zero path difference, all wavelengths will be in-phase. This result in the interferogram 
which is converted to a single beam spectrum by means of a Fourier transform 
mathematical function.
3.3.6 Advantages o f FT-IR over traditional instruments
• Jacquinot or throughput advantage:98,102 FT-IR doesn’t employ any slits and the 
resolution is defined by the path length of the moving mirror.
• Felgett or multiplex advantage:98,102 the detector observes all the frequencies 
concurrently, and the time taken is considerably reduced and the signal to noise 
ratio is increased.
• Connes advantage:98,102 the accuracy of the Wavenumber measured is enhanced 
due to the internal He-Ne reference lasers which not only monitor the movement 
of the mirrors, but also calibrates the wavelength.
The interferometer modulates the IR frequency differently thereby stray light impact is 
reduced.98
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Figure 3.2. Michelson Interferometer with FT-IR components
3.3.7 Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy 
Attenuated Total Reflectance is a total internal reflection sampling technique and is 
widely used for measuring IR spectra103 and the schematic representation is shown in 
Figure 3.3. In ATR, the sample has to be placed in close optical contact with the ATR 
crystal.96 The ATR crystal, also called the denser medium, is made from a high 
refractive material like Zinc Selenide (refractive index is 2.54), Diamond (refractive 
index is 2.4), Germanium, Silicon or Thallium-Iodide,103 etc. O f the available ATR 
crystals, diamond is widely used because it is thermally stable. The sample also called 
the rarer medium has a low refractive index compared to the ATR crystal. Although, 
there is total internal reflection at the surface, a small amount of the radiation does 
penetrate a short distance into the sample.97 The penetration is the evanescent wave and 
the absorption of this energy at a particular wavenumber leads to the surface specific 
spectrum this can relate to a surface equal to 2-10 pm.103 The evanescent wave and its 
intensity or penetration depth decays exponentially with increasing distance from the 
interface. The penetration depth (dp) of the evanescent wave at the interface could be
0 7calculated using the following equation, which is as follows;
d A (7)
where;
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dp is the penetration depth in pm,
X is the wavelength in pm,
6 is the angle of incidence,
nj and ni are the refractive indices of the crystal and sample respectively.
From the equation it is clear that depth of penetration increases with X at constant 6, n i 
and ri2  while it decreases with increasing 6 at constant X, ni and ri2 .96 However, other 
factors affecting the ATR spectrum include,97
1. Angle of incidence which must be greater than the critical angle (6C)  and given 
as 6C = s in 1 (n2/ni).
2. Wavelength of the radiation and
3. Refractive indices of the sample and the crystal which governs the nature of 
interaction of the radiation at the interface.
O
sin 0-me2m
 -
Figure 3.3. Schematic representation of attenuated total reflection
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3.4 Spectroscopic Imaging
3.4.1 Introduction
Spectroscopic imaging is also known as chemical imaging or hyperspectral imaging. 
Infrared microspectroscopy using prism monochromator was made available during the 
1940’s104, but the performances of these instruments were marginal.105 The first true 
chemical imaging104,105 was reported in the mid 1990’s. With the imaging 
investigations, apart from the conventional spectroscopic benefits, the distribution and 
location of the individual components within the mixture can be established.106,107 These 
advancements enhanced the chemical characterization of samples on a microscopic 
scale, its morphological form (typically polymorphs and hydrates).106,108,109 Thousands 
of infrared spectra with near-diffraction limited spatial resolution and moderate spectral 
resolution can be acquired in minutes depending on the instrumentation type.105 More
107recently applications have involved real time analysis o f  Complex systems.
The aforementioned vibrational spectroscopic imaging can be approached by single­
point measurements or mapping or imaging. In the single-point measurements, firstly, 
the sample is visually inspected for desirable features using optical microscopy.105 Then 
the spatial localization is accomplished by restricting the incident radiation at the 
sample plane.108 This is achieved by placing an opaque mask with an aperture of 
controlled size.108,110 Spectra are then acquired using single element detector. The 
microscopic stage is then moved to record spectra from other regions.104 Precise 
positioning, accuracy and longer time of analysis make this approach undesirable.108'110
The application of infrared microscopy, when coupled to a dispersive instrument, is 
severely hampered by the low amount of energy passing through the aperture onto the 
sample from the grating. This can be overcome by the use of an interferometer where all 
wavelengths o f light are measured simultaneously.105,108,111,112 This technique involves 
sequential measurement of neighbouring points one at a time.105,106,113 If these 
measurements are done in one direction (x-axis), it is termed as line 
mapping.104,108,114,115 Moreover, it is possible to move and measure the spectra in both x, 
y directions. Although this resembles imaging measurements, since the spectra are not 
acquired using array detectors it is still a mapping technique.105,108,110
Imaging utilizes a focal plane array (FPA) detector, were the radiation from the sample 
plane is segmented at the detector plane106,108 and is referred to as hyperspectral
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imaging.105,108,109 FPA detectors enable one to acquire thousands of spectra 
simultaneously and have become increasingly popular in the recent years.104
Spectroscopic or hyperspectral imaging can be accomplished by measuring the mid- 
infrared, near-infrared or the Raman spectrum.104 In near infrared and Raman, the signal 
at a given wavelength is recorded at each pixel.104,105 With the NIR chemical imaging, 
the light is passed to a monochromator or liquid crystal tunable filter (LCTF).105 The 
radiation is then passed onto the sample and the signal from the sample is acquired by 
the array detector. The image from one wavelength is measured at all pixels 
simultaneously. The wavelength is then changed and the process is repeated until all the 
wavelengths are measured.
The monochromator is also located before the sample in Raman Imaging.105 With 
Raman imaging, the signal to noise ratio is good, therefore longer integration times are 
required, also, collection times are longer as a typical Raman dispersion element will 
only collect data covering a ‘spectral window’ of around 600 cm'1 at a resolution of 2 
cm'1. In the NIR imaging, the signal to noise ratio is low but the images can be acquired 
rapidly. The spectral resolution in both the measurements is determined by the optics 
(band pass of the monochromator or the filter).
In mid-infrared imaging,104,105,108,116 the array detectors are coupled to an interferometer. 
Interferogram from the different regions are acquired simultaneously, after which it is 
Fourier transformed to yield the desired hyperspectral data.
3.4.2 Infrared imaging background
Infrared imaging utilizes a focal plane array (FPA) detector and allows measurement of 
spatially resolved images117,118 which carries spectral information.105 Chemical imaging 
combines the benefits of digital imaging and the spectroscopy. The driving force behind 
this technology jump is the availability of multi-channel detectors105 and the 
development of efficient chemometric tools.108"110,117,119,120 The acquisition of chemical 
images using linear array of detector is called pushbroom approach whereas acquisition 
using 2-D array detectors is called quilting or mosaicing.105
3.4.3 Instrumentation
The marriage between the traditional techniques like microscopy, infrared spectroscopy,
interferometry and focal plane array detectors (FPA) have led to the fast development of
the Fourier transform infrared chemical imaging105,108,110,117,121 (shown in Figure 3.4).
Infrared microscopes differ from optical microscopes in physical construction and
source. Since glass doesn’t transmit radiation of wavelength longer that 4.5 pm all
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reflective Schwarzschild objective is used.105 Radiation selection optics are designed for 
flexibility in switching between visible and infrared light. That is, the regions of interest 
can be selected using visible light source while data collection or scanning is carried out 
using infrared light. Moreover, to increase the spot size and spatial homogeneity/field of 
view (FOV) diverging lenses like lightly sanded KRS-5 are used.105,108 
The infrared microscope is interfaced to a Michelson interferometer for the imaging 
studies and requires the Fourier transform mathematical procedure to convert the 
interference pattern (intensity path difference from the static and moving mirror) to 
spectra generated by the interferometer.102 There are two scan modes available, 
continuous scan and step scan. If the moving mirror is scanned at a constant rate 
between data collection points it results in continuous scan process and often used for 
steady state measurements. When the moving mirror is stopped and dithered at fixed 
distances over the length of the data collection sweep, the collected data can be 
recombined to form an interferogram and this process is known as ‘step-scan\105,108 
Step scan mode will be a powerful tool for studying spectroscopic changes occurring on 
the nanosecond or microsecond time scale. The primary advantage of operating 
interferometer in continuous scan mode is reduced instrument cost (no additional 
hardware or software modifications required) and increased data collection efficiency
I HR(mirror stabilisation time is eliminated).
The infrared microscopes and interferometer are then assembled to the multichannel or
large format array detectors arranged in two dimensional grid patterns.105,108 The earliest
FPA detectors were made from indium antimonide (InSb) but were replaced quickly
due to low spatial area focus (500 pm x 500 pm) and high cut off (1800 cm '1). These
were replaced with mid-IR mercury-cadmium-telluride (HgCdTe) focal plane array
(MCT-FPA) detectors. The imaging FPA detectors operate in the photovoltaic (PV)
mode rather than the conventional photoconductive mode MCT detectors.
Consequently, the cut-off wavenumber for the PV-MCT is at about -850 cm '1 and MCT
detectors operate effectively at -20 °C, hence requires cryogenic cooling.105
The infrared sources used in the laboratory based instruments are incandescent (silicon
• carbide) Globar sources.102,105 Other sources are synchrotron and free electron laser but
the sample has to be moved from labs. The modulated radiation from the source is
passed through the apertureless Schwarzschild optics which is then focussed on to the
sample. The entire field of view (FOV) or region of interest in the sample is illuminated
and is recorded by the large format MCT-FPA detectors. As mentioned previously, the
FPA’s are operated in the photovoltaic mode; hence the FPA response is triggered by
27
the interferometer. At each trigger, the pixel responses are read in snapshot mode.105 
That is, all the pixel responses are read simultaneously, processed and transferred to the 
data system to provide an interferogram. The interferogram is then Fourier transformed.
The chemical image can be viewed as a 3D block termed as hypercube comprising of 
two spatial (x, y) and one wavelength (z) dimension104,110,122 (Figure 3.5). Each data 
point in the cube provides spectral information, and the process of acquiring the image 
is called as hyperspectral imaging. Single data point in the image is termed as the pixel 
(ID) which yields spectral information while the collection of pixels represents image 
plane or channel (2D) and carries information on spatial and distribution patterns within 
the selected system.104,115,123
A variety o f sampling techniques have been utilised in spectroscopic imaging 
experiments like transmission or external reflection like reflection-absorption, specular 
reflectance or diffuse reflectance techniques and attenuated total reflection sampling 
modes are utilised. However, these choices depend upon nature and thickness of the 
sample.105,108
Binoculars
M ultichannel FPA 
“" S . DetectorCamera
FTIR Spectrometer
View/Scan 
Selection Optics
Shared 
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Transmission 
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Transmission 
Mode Condenser Visible Radiation
Figure 3.4. Schematic representation of FTIR chemical imaging
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30 Figure 3.5. Schematic representation of a data cube generated during mid infrared chemical imaging experiment
3.4.4 Resolution
The performances o f the FTIR imaging systems are limited by the identity of the
10Rsample, physical state of the sample or particle size of the sample. However, these 
limitations are discussed as resolution limit (spatial, spectral and temporal). Although 
these systems do not have apertures for image collection, the detector elements are of 
finite size. That is, each pixel size resolution or spatial resolution is 5.5 pm .105,102 
Spectral resolution is governed by the distance that the moving mirror travels; longer 
distances provide a higher resolution, but there will be a time penalty at a fixed velocity. 
There will also be a S/N penalty at higher spectral resolution as the system is detector 
noise limited, therefore a compromise between acceptable acquisition time, S/N and
10Rspectral resolution has to be made.
3.4.5 Signal to noise ratio (SNR)
To obtain spectra or image at high fidelity the signal to noise ratio is considered as the 
performance characteristics of the imaging system. The major efforts to improve the 
SNR can be divided into four categories which are hardware modifications, signal or 
data acquisition protocols, image transformation schemes and post data refinement 
protocols,108 shown in Table 3.2.
3.5 Thermogravimetry-Mass Spectrometry or Evolved Gas Analysis
Thermoanalytical techniques are universal tools in which the changes in a physical
1 <7*7property of a material are monitored continually as a function of temperature. For 
example, with thermogravimetric analysis or differential thermal analysis, the changes 
in the sample weight or thermal events during programmed temperature treatment are 
recorded.127,128 It is useful for measuring physical or thermal properties, composition 
and stability o f the materials.128'130 However, often the obtained results lack chemical 
and analytical information.127,128,130,131
For complete characterisation of a compound, simultaneous techniques that can provide 
complementary information will be useful.127 Thus, coupling thermal analysis like TGA 
with mass spectrometry or infrared spectroscopy allows evolved gases to be analysed 
and identified; supplementing the required information.130 O f the available choices, 
coupling mass spectrometry with TGA is preferred because of the advantages like high 
specificity, sensitivity, fast response, low detection limit, multiple ion and isotope 
detection abilities.130 Evolved Gas Analysis (EGA) is a technique in which the nature 
and/or amount of volatile products released by the substance which can be residual
31
1 90 1solvents, degradation products, moisture, etc. are studied. ’ Samples under 
investigation can be subjected to isothermal or ramping temperature treatments.
The thermogravimetric measurements require thermobalance or precision balance 
(made of material depending upon experimental temperature range, sample quantity, 
etc.) operating with a temperature programmed furnace.127 Mass spectrometers compose 
of ion source, mass filter and ion detector.128' 130 The TG instrument works at 
atmospheric pressure (typically 103 mbar) while mass spectrometer works under high 
vacuum (typically 10'5 mbar).129 Therefore an interface for reducing pressure is required 
to couple thermobalance to the mass-spectrometer which depends upon instrumentation
i n o  i 09 , ,and applications. ’ A schematic diagram of such an instrument is shown in Figure 
3.6.
During the measurement, a sample weighing few milligrams is placed in a refractory 
crucible which is subjected to isothermal or ramping temperature program. Also the 
weight is recorded in the instrument by means of a sensitive balance.130 The 
measurements can be performed from 25 °C to 1000 °C (or higher) in the presence of 
air or nitrogen. The quality of the data is influenced by the sample size, carrier gas,
sample holder or heating rate. 133
Purge Gas
■■ '1(P mbar" '“ IF'..-
Interface
1 O'5 mbar
Pump
Thermobalance Mass Spectrometer
Figure 3.6. Schematic representation of TG-MS instrument
Moreover, these hyphenated techniques can also be combined to enable the differential 
thermal analysis (DTA) function.127 DTA may be defined as a technique for recording 
the difference in temperature between a sample and a reference material against either 
time or temperature program.130 DTA measurements are useful in studying 
decomposition, dehydration, glass transition, melting etc. DTA results are useful in the 
better understanding of results from spectroscopic and thermogravimetric studies.
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The output of such measurements is a thermogram or TG curve (Figure 3.7), derivative 
thermogram or DTG curve (Figure 3.8), differential thermal analysis curve or DTA 
curve (Figure 3.9), mass spectra or ion chromatogram (Figure 3.10). The thermogram 
shows the weight loss o f the sample as it is heated which could be due to evaporation or 
degradation. Derivative thermogram is a mathematical manipulation to determine any 
subtle differences in the TG weight loss curve. The DTA curve shows the plot o f 
temperature difference between sample material and reference material (mW/mg) 
against temperature (in °C). The exothermic events could be due to melting, Tg or 
degradation. The mass spectra or ion chromatogram is the plot o f ion current against 
time (minutes) or temperature (°C). These are model representation and will be 
discussed in detail in the results and discussion section in the following Chapters.
3.6 Data Processing Tools
3.6.1 Univariate analysis
A univariate technique uses only one variation within the dataset to categorise the 
sample under investigation. When the sample contains few components with non­
overlapping bands then the peak height or peak area measurements can be used to 
identify the components.113 The method is fast, simple to understand and easy to 
calculate. However, it is well suited for uncomplicated samples and binary mixtures 
only. The method does suffer in distinguishing complex mixture samples; sample purity 
is also an important factor, which restricts its usage. The other drawbacks with the 
univariate techniques are that optical linearities are encountered.
3.6.2 Multivariate analysis
With complex systems there is high probability of overlapping bands making the 
identification more complicated.113 To overcome this multivariate data analysis is done.
a. Compare Correlation
Correlation mapping or compare correlation is a class of statistical pattern recognition 
approaches where the samples under investigation are classified according to a specific 
physical or chemical property.134 The property of interest used to describe each sample 
within the dataset is called a pattern. A set of samples whose property is defined and 
known are called a training set or reference samples. Moreover, when the samples are
1 3Sclassified based on a property or pattern it is termed recognition. The most common 
assumption made is that the data set has Gaussian like distribution and then the data are 
classified by their mean and covariance.
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The aforementioned classification systems are better expressed as correlation coefficient 
values which measures similarity or dissimilarity between the sample and the training 
dataset. The correlation coefficient values or simply correlation scale ranges between 0 
and 1, with 1 being perfect correlation between two data or spectra. In order to 
differentiate these numerical values, each region is assigned different colours like blue, 
green and red and each colour represent correlation. These values are basically 
qualitative parameters used to better understand the homogeneity in distribution or 
phase separation,136 etc. A correlation value. between 0.99 and 0.80 (assigned red) 
indicates that the regions in the sample belong to the reference product to which it is 
compared; correlation value less that 0.5 indicates absence of similarity (assigned blue). 
The intermediate values would require cautious interpretation.
b. Principal Component Analysis
With complex systems there is high probability of overlapping bands due to the 
presence o f multiple components within each pixel, making the identification more 
complicated.113 To overcome this multivariate data analysis is done. One of the 
frequently applied tools is the Principal Component Analysis (PCA).
Principal Component Analysis (PCA) is widely used to reduce the dimensionality of the 
data that would contain large amount of information. Moreover, it is mainly applied to 
unravel the overlapping spectroscopic features and helps to identify a number of pure 
components present in the sample.113 There are many ways to identify and one such 
method is to generate eigenvalues which are scalars. This is done iteratively and 
principal components are identified, however, assumption is that the signal collected is 
linearly related to concentration.
The maximum variance is explained by the first principal component (PC) and the 
second PC is constructed orthogonal to the first PC which explains the residual variance 
and so on104 with additional PC’s. Thus, PCA decomposes the complex data into 
sections of signal and noise,113 moreover, the first few PC’s explain the maximum 
variance or eigenvalues. The PC eigenvalues decrease with number of components and 
level off when the complete signal is calculated. The signal/noise can be increased by 
removing the noise from the data. The result of the analysis is discussed in terms of 
scores and loadings.104 Loadings are the number of components that have detectable
113signal while the scores are related to the concentration of the components.
PCA sometimes can provide inconclusive or overestimated results. Hence, working 
knowledge on how many components present in the sample is pre-requisite. Cross-
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validation schemes like box-plot, F-test of the variance or the predicted residual error of 
the sum of squares are being widely used conjunctively to aid the better understanding 
the results.
c. Multivariate Curve Resolution-Alternating Least Squares
Multivariate Curve Resolution (MCR) is a chemometric multivariate approach and is a 
class of bilinear self-modelling curve resolution methods.137,138 MCR is useful in 
analyzing large data matrices. Moreover, it does not require any prior knowledge about 
the sample, spectral corrections or manipulations but rather utilizes the raw data files. A 
detailed description can be found elsewhere.137,138
The main objective of MCR is to mathematically decompose the large amount o f 
spectral data from the multi-component mixtures to pure spectra or pure intensities of 
the individual components. The MCR works by initially applying principal factor 
analysis (PFA) in order to recognise the pattern involved in the studied data. In this step, 
the PFA looks for major trends and categorises the data based on the varying factors. In 
the following step, alternating least squares (ALS) is applied to convert the 
mathematical results to more meaningful analytical data. A range of constraints can be 
applied to extract further information.139
Since the raw spectral data files contain noise associated with the measurements,140 the 
predicted model can produce solutions (called principal factors) that fit mathematically, 
but do not carry any physical or chemical meaning and this uncertainty is called 
rotational or intensity ambiguities.138,141' 144 Hence, choosing the optimal number of 
factors is an issue so prior working knowledge about the sample is helpful. Additionally, 
application of exploratory data analysis is vital. Studies have shown that when the 
system is rank-deficient or homogenous, conventional MCR is unable to distinguish or 
extract all of the components. New approaches are being adapted to handle these 
uncertainties.136,142,144
The advantages and disadvantages of univariate, compare correlation, principal 
component analysis and multivariate curve resolution are shown in Table 3.3.
3.7 Statistical Analysis
In order to better interpret any experimental data, statistical significance testing is
applied. Many statistical procedures are available to perform this. However, analysis of
variance (ANOVA) is the procedure of choice. ANOVA is an example of a parametric
statistical test. It is a very useful measure to compare similarity or differences among or
36
within means from different groups. All analysis is done at a 95% confidence level, as it 
is a common practice in pharmaceutical analysis.
Two way analysis of variance allows is carried out to understand the influence of 
temperature (30 °C, 40 °C, 50 °C) and sample (for example, binary solvent mixture, 
100% drug, 100% polymer, various drug loaded solid dispersions) on the evaporation 
rate of solvents and formation rate of solid dispersions. ANOVA results are interpreted 
by taking into consideration of the F-values, Fcrit-values and P-values. The ANOVA F- 
value is a ratio of the variance of the between group means divided by the variance of 
the within group means. A P-value is a measure of how much evidence we have in 
obtaining the result. If F-values are larger than the Fcrjt-values (F > Fcr;t) and if P-value is 
less than 0.05 (that is 5% significance testing) then any changes interpreted are 
significant (numerates are indicated in green), if F < Fcrit; P > 0.005 then the results are 
insignificant and numerates are indicated in red. Unfortunately, ANOVA does not show 
were the difference lies.
Least Significant Difference (LSD) tables can be constructed from ANOVA results to 
further explore any significant changes between the measurements. LSD is a method 
used to make multiple comparisons between various treatments to ascertain where the 
difference lies. At the chosen level of significance, for each set of data a statistical value 
is calculated. The calculated value is then correlated with the results obtained from the 
experiments. If the difference between two temperature/sample means is greater than 
this calculated value then there is significant difference between the compared data and 
the values are coloured green, otherwise red.
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C h a p t e r  4.
T h e  A p p l ic a t io n  o f  V ib r a t io n a l  Sp e c t r o s c o p y  t o  
S o l id  D is p e r s io n s : K in e t ic s  o f  So l v e n t  E v a p o r a t io n  
A n d  D r y in g  ________________  ' ____________________ _
4.1 Introduction
In order to understand the structure of solid dispersions, crystallization kinetics, drug- 
polymer-excipient interactions, molecular mobility and thermodynamics of the 
molecular state a wide range of analytical methods have been used to characterise the 
prepared solid dispersions.47 However, real time or in situ measurements are required to 
understand the dynamics of solvent evaporation and formation of solid dispersions. Real 
time measurements using a wide range of analytical instruments have proven 
indispensable in many fields. For example, FTIR spectroscopy,145' 161 Raman 
spectroscopy,147,162' 164 Near infrared spectroscopy, Nuclear Magnetic Resonance 
spectroscopy,165 X-Ray Diffraction,166>167 Surface Circular Dichroism, Neutron 
Scattering,168 Small-Angle X-ray scattering169 and Differential Scanning Calorimetry162 
have been used to understand the polymerisation, polymorphism, granulation process, 
topical drug delivery, dissolution, coatings and catalysis. Particular reasons for using IR 
are molecular specificity, signal strength, non-destructive nature and extreme sensitivity 
to subtle matrix and environment changes.170 In particularly, the FTIR-Attenuated Total 
Reflectance mode has been the technique of choice in many fields like catalysis,149,171 
clay nano-composites,150 polymerisation,151,153,161 corrosion158'160 and gelation.153,157 In 
the pharmaceutical field FTIR-ATR (spectroscopy and imaging) in situ measurements 
are widely used to study the crystallisation,172 polymorphism,147 tablet compaction,173 
super critical carbon dioxide (SCCO2) polymer-drug formulation40 and dissolution 
testing.164
The main objective of this work is the application of vibrational spectroscopy to 
understand the dynamics involved in solid dispersion formation. To the best of our 
knowledge this is the first time in situ FTIR-ATR has been applied to solid dispersions 
to address the following questions:
1. Can FTIR-ATR be applied to follow the rate of film or solid dispersion 
formation?
2. Does temperature have any effect on the nature of film formation?
3. Can spectroscopy be used to interpret molecular interactions (solvent-solvent, 
solvent-solid interactions and solid-solid interactions)?
39
4. Can spectroscopy be used to determine the final product characteristics based on 
temperature, solvent selection and drug loading?
To answer these questions, a model drug, felodipine and polymer, Polyvinyl 
pyrrolidone (PVP) were selected. Solvents (methanol, acetone and dichloromethane) 
were selected based on volatility, Gutmann’s acceptor-donor numbers, density and 
refractive index as shown in Table 4.1.
In the preparation of solid dispersions one of the key components is the choice of 
solvent, because physical mixing of the drug and polymer would not yield solid 
dispersions. The drug and the polymer are mixed in a common solvent, and evaporation 
yields intimately mixed solid dispersions. Many other methods are available and details 
can be found elsewhere.7,10,28 Solvent nature, Gutmann’s acceptor-donor numbers and 
density are some of the factors that are the important while selecting the solvents. 
Spectroscopic studies have shown that solvents can alter molecular interactions of 1,4 
dihydropyridine,31 swelling behaviour of hydrogels,32 change in the Conformation of 
gramicidin33 and alter the denaturation of urea.34,35 These effects are characterised by 
the solvent induced frequency shifts31 (SIFS) in carbonyl moieties and other groups 
involved in the intermolecular interactions.
Of the available analytical techniques, IR spectroscopy is widely used in investigating 
the drug-excipient interactions with the pharmaceutical formulations and hydrogen 
bonding in all states of matter.37,174,175 The important characteristics studied are the 
appearance of new IR absorption bands, broadening of bands and changes in the peak
37 96 176intensities and position. ’ ’
4.2 Experimental part
4.2.1 Materials
Materials used are a model drug, felodipine (AstraZeneca, U.K) and the model polymer, 
polyvinylpyrrolidone (Plasdone K29/32, average molecular weight = 58,000), the latter 
being purchased from ISP. Acetone, dichloromethane and methanol (HPLC grades) 
were obtained from Sigma-Aldrich, Switzerland. Unless stated, the drug, the polymer 
and the solvents received were used as obtained.
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4.2.2 Sample preparation
Three different drug-carrier weight ratios (20:80, 50:50 and 80:20) for binary systems, 
100% drug or 100% polymer and two different mixed solvent systems 
(acetone/methanol and DCM/acetone at 50:50, v/v) were used. 1 g of the solid was 
dissolved in 25 ml of the solvents to yield 4 wt% solutions. 50 pi of each solution was 
cast directly onto a pre-heated ATR crystal using a Gilson pipette. Studies were carried 
out at 30 °C, 40 °C and 50 °C. Each experiment was measured in 5 replicates to ensure 
reproducibility.
4.2.3 Experimental Parameters
FTIR spectra were collected using a variable temperature Graseby Specac single 
reflection diamond ATR attached to a Thermo Nicolet Nexus bench equipped with a 
Mercury-Cadmium-Telluride detector. The spectra were collected between 4000-650 
cm*1 at a resolution of 4 cm*1 using 4 co-added scans. Since the formation of solid 
dispersions from mixed solvents proceeded at a rapid rate, the total experimental time 
was kept short and a time of 2 seconds was required for the 4 scans. The spectra were 
collected continuously (series) over a pre-determined period of 5 minutes. All the 
spectra during the kinetic study were collected in the Log (1/R) format. Background 
spectra of the blank ATR crystal were collected before each experiment. The ATR 
crystal was heated to a predetermined temperature and allowed to equilibrate. 50 pi of 
the prepared drug polymer solution is placed on to the ATR crystal. As soon as the 
solution is pippetted out onto the crystal, the initial data are dominated by the solvent 
spectra. As the solvents start to evaporate, drug and/or polymer bands appear in the 
evanescent wave and their spectrum is observed. The spectral changes are monitored 
and recorded.
4.2.4 Multivariate Curve Resolution
The purpose of using multivariate curve resolution (MCR) is to mathematically 
decompose the large amount and overlapping spectral data from the multi-component 
mixtures to pure spectra and pure intensities. The series runs were split into individual 
spectra which were then converted to a multifile using GRAMS. The compatible 
multifile was then loaded onto the MCR software version 3.19.04 (Courtesy: Dr. 
Thomas Hancewicz, Sr. Project Scientist, Unilever R&D, USA).140,178,179 To achieve 
this, the following parameters were chosen to carry out the MCR procedure on the 
spectral data matrix:
1. Pure variable selection - Principal Factor Analysis
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2. Transformation-Alternating Least Squares (ALS)
3. Constraints -  Modified Alternating Least Squares (MALS-2D)
4. Maximum Iterations -  500 times
5. Data display -  Rastering mode
6. Optimal number of factors -  Prior knowledge about the sample
4.2.5 Statistical Analysis
In order to better interpret the kinetic data, statistical significance testing was applied. 
Many statistical procedures are available to perform this. However, analysis o f variance 
(ANOVA) is the procedure of choice. ANOVA is an example of a parametric statistical 
test. It is a very useful measure to compare similarity or differences among or within 
means from different groups. Unfortunately, ANOVA does not show were the difference 
lies. Least Significant Difference (LSD) tables were then constructed from the ANOVA 
results to further explore any significant changes. LSD is a method to make multiple 
comparisons between the various treatments to ascertain where the difference lies. All 
the analysis was done at 95% confidence level.
4.3 Results
As a first step, typical infrared spectra for each of the pure components were obtained 
and are shown in Figure 4.1 A to E.
The main objective of the study is to monitor in real time the evaporation of solvents and 
formation of solids. Due to potential complexity of the system under investigation with 
overlapping infrared bands, before considering any measurements on drying solutions, it 
is required to select a single discriminating band for a component of interest in the 
mixture.' The characteristic peaks selected are listed in Table 4.2. Moreover, the peak 
height measurements were chosen instead of the widely used peak area approach. 
Changes in intensity with time can be related to the relative concentration of the 
components within the 10 pm layer closest to the ATR crystal (depth of penetration, dp 
= 2 to 10 pm). Typical spectral changes for felodipine/polyvinylpyrrolidone cast from 
acetone/methanol arid dichloromethane/ acetone are shown in Figure 4.2 and Figure 4.3, 
respectively.
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Figure 4.3 Spectral changes as a function of relative intensities-Fel/PVP solid dispersions cast from DCM/Acetone mixture 
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The kinetic or absorbance profiles for each of the components were then extracted from 
the data by plotting log (1/R) of a characteristic peak over time. The next step was to 
carry out a normalisation procedure. The normalisation procedure is as follows. For 
each profile, the data point with the lowest intensity was identified and this value 
subtracted from all data points within the data series. Then, the data point with the 
highest value was identified and all data points within the series were divided by this 
value, resulting in a profile that ranged between 0 and 1. Typical kinetic profiles after 
normalisation for the two different systems (felodipine/PVP cast from acetone/methanol 
and felodipine/PVP cast from DCM/acetone) are shown in Figure 4.4 and Figure 4.5, 
respectively.
The plots of intensity versus time appeared to be pseudo-sigmoidal in shape. The 
decrease in the intensity of the solvent peak is indicative of evaporation and the increase 
in the intensity of the drug/polymer peaks is indicative of solid dispersion formation. 
The relative volatility of the solvents used and the depth of the layer sampled by the 
evanescent wave are the key parameters during the evaporation process. Let us consider 
the acetone/methanol mixture. Since acetone is more volatile than methanol, it 
evaporates first causing an increase in the methanol proportion in the evanescent wave 
(or 10 pm sampling zone). Subsequently, methanol evaporates leaving the solid 
dispersion and this accounts for the maximum in methanol intensity in Figure 4.4B. 
However, in the DCM/Acetone mixture the rate of evaporation of DCM is somewhat 
faster (due to it being more volatile) than acetone causing an initial slight increase in the
i
acetone proportion (Figure 4.5B).
4.3.1 Extraction o f  kinetic information -  Peak Height Measurements 
The kinetic profiles obtained as a result of solvent evaporation and solid formation 
studies are shown in Figure 4.4 and Figure 4.5. Firstly, it would be o f interest to 
calculate the slope o f the tangent and then derive the rate of the process. But this 
approach was not successful as slopes for each of the components was very similar and 
useful information was not readily obtained.
In order to fully utilise the kinetic information, the transition region in Figures 4.4 and 
Figure 4.5 was used to extract the time taken for solvent concentration to drop to 50% 
and 10% of its original value are termed tsoand t\o, respectively. Similarly the time 
taken for the solid concentration to rise to 50% and 90% of its final value are termed as 
tso and tgo. Generally throughout this chapter the kinetics of solvent evaporation and
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solid formation will be represented as tso/tso or /50 and / 10//90 or f 10 or /90, respectively. A 
straight line of best fiCwas used in the transition region in order to better estimate the 
times corresponding to t\o, tso and /90, for example, between 30 (s) and 40 (s) on the 
solvent evaporation curve in Figure 4.6A. t\o, /50 and /90, always fell in the transition 
region rather than on the other parts of the curves representing slower evaporation of 
solvent or formation of solids and therefore justifies this methodology.
Figure 4.8A, B, C and D shows values generated for tso/tso studies at various 
temperatures and different samples (binary solvent mixture, 1 0 0 % pure drug, 1 0 0 % 
pure polymer and various drug loaded solid dispersions). The error bars indicate 
reproducibility based on 5 replicates. The errors bars indicated here correspond to ± 1 
standard deviation. From Figure 4.8. A-D, it can be seen that generally a rank order or 
interpreting interactions was not possible from these measurements. Values for /10 and 
/9 0  or tio/tgo obtained in this way at the three different temperatures and for both solvent 
systems under investigation are shown in Figures 4.9 and 4.10 (A-D), respectively. Of 
the abovementioned approaches, the t\o/t% values were found to be promising and the 
obtained results will be discussed in the following sections.
Acetone /10 measurements (in acetone/methanol mixtures) proved to be problematic, as 
can be seen from Figure 4.4A: here the peak intensity passes through a minimum, before 
gradually increasing at longer times. The cause of this artefact is the presence of 
overlapping features in the carbonyl region, with contributions from both drug and 
polymer. In order to attempt a better interpretation of the acetone evaporation, a 
Multivariate Curve Resolution approach was utilised.
4.3.2 Extraction o f kinetic information -  Multivariate Curve Resolution
A typical profile extracted from MCR is shown in Figure 4.7A. The MCR analysis 
extracts spectra-like factors that can be used to interpret which components are changing 
as a function of concentration and time. From the 20% Drug loaded felodipine/PVP 
solid dispersion data, four factors are derived, of which factors I and II reflect a chemical 
species that is being lost over time. These factors represent solvents. Factor III is 
growing at a rate comparable to the loss of factors I and II. These findings are analogous 
to the peak height measurements. The factor IV initially grows. However, this factor 
drops when the solvents disappear from the system. Figure 4.7B-E, shows the extracted 
‘pure component’ factors from the MCR-ALS analysis which is compared to ‘real’ pure 
components. MCR factor I, II, III and IV show similarities to the pure spectrum of 
acetone, methanol, PVP and felodipine, respectively.
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MCR analysis is particularly useful as compared to peak height measurements in the 
way that it extracts the factors which can be directly compared with real pure 
components. Moreover, studies have shown that the concentration profile extracted 
using MCR can be used to obtain quantitative information137,140,178,180,181 and in our 
kinetic studies this was utilised to calculate the ho acetone results from the kinetic 
intensity profiles. Moreover, the t\o MCR results of methanol, felodipine and PVP were 
compared for similarity with peak height results. The forms of the MCR kinetic profiles 
extracted matched the profiles from the peak height measurements, which gives us 
confidence in interpreting the t\$ acetone results.
4.3.3 Statistical Analysis
However, significant differences in the results were obtained only with t\o methanol 
measurements. This is due to the fact that the multi-component mixtures give rise to 
overlapping features masking the characteristics of the other components within the 
mixture. As a result, statistical analysis has been carried out to better understand the 
kinetic results. Statistical analysis, most importantly, analysis of variance (ANOVA) and 
Least Significant Difference (LSD), has previously been widely applied in different 
fields of materials science and will be used in our studies at 95% confidence interval.
4.3.4 Thermogravimetry/Mass Spectrometry
TG-MS was applied to study trapped/residual solvent in felodipine/PVP (acetone or 
methanol or both) to complement the in situ FTIR experimental results. Samples used 
were blank or buoyancy correction files, binary solvent mixtures (BSM’s, 
acetone/methanol), 100% drug and 100% polymer in acetone/methanol. The 
experiments were performed in triplicate. The initial temperature was set at 25 °C and 
the temperature was ramped to 30 °C over 14 minutes and maintained at this 
temperature for 46 minutes. After which, it was ramped to 320 °C at = 20 °C/min and 
this temperature was reached within 16 minutes. The total analysis time was 76 minutes. 
Monitoring residual solvent was the prime objective hence evolved solvents over time 
were studied, mass/charge ratios (m/z) corresponding to acetone and methanol were 
selected. These m/z ratios were monitored over the analysis time and a profile was 
plotted. For methanol m/z = 31 (due to fragment C H 3O*) and for acetone m/z = 41 (due 
to fragment CH 3 CO*) were used to measure the residual solvents. The solvent profiles 
from TG-MS (Figure 4.12) are similar to FTIR kinetic profile (Figure 4.4A and Figure 
4.4B), that is, acetone evaporates first, followed by methanol, which is attributable to 
volatility and molecular interactions. The amount of residual solvents at two
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temperatures, 27 °C and 30 °C were studied (Figure 4.12A, B and C) and the results of 
these measurements are discussed in the following sections.
4.4 Discussion
4.4.1 Surface tension and Wettability
From the data in Table 4.1, it can be seen that the surface tension for the components 
studied are very similar and as a result, the drop placed onto the ATR crystal completely 
covers the crystal, resulting in no issues with the wettability. That is, the solvents and the 
solids remained in close contact with the ATR crystal throughout the measurements.
4.4.2 Thickness o f the Final Product
The final thickness was estimated to be ~7 pm based on the fixed volume (50 pi), a 
polymer density o f 1.23 g/dm3 and a final film area o f 471 mm2, meaning that the 
sample thickness was always greater than the depth of penetration. Optical 
measurements indicated a film thickness of ~6-7 pm.
4.4.3 The Applicability of Raoult’s law and Henry’s Law
The relationship between the vapour pressure and concentration is given by Raoult's 
law, which states that: “the vapour pressure of a solvent in the solution is equal to the 
vapour pressure of the pure solvent multiplied by its mole fraction in the solution”.
At equilibrium, for a binary mixture (A and B) the law is expressed as
Ptotal =  P a M a  + P b M b  .....................  (4.1)
where; P totai is the total vapour pressure of the binary mixtures; P a  and R^are the partial 
vapour pressures of A and B respectively; Ma and Mb are mole fractions for A and B 
respectively.
This law holds good for mixtures where between intermolecular interactions (A...B) are 
similar to within molecular interactions (A...A and B...B).182-184 These type of mixtures 
are called ideal solutions. That is, A...B intermolecular interactions = A...A and B...B 
interactions.
However when two different liquids are mixed, there are possibilities for increased or
183decreased interaction between liquids when compared to the pure solvent alone . 
These mixtures deviating from the law can be grouped as follows,182
1. When the intermolecular interaction is reduced on mixing, the total vapour 
pressure of the mixture will be increased but this number does not exceed the 
maximum value of either pure solvent, a positive deviation. (Condition: A...B < 
A...A or B...B)
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2. When the intermolecular interaction is increased on mixing, the total vapour 
pressure of the mixture will be decreased but not smaller than pure solvent 
values, a negative deviation. (Condition: A...B > A...A or B...B)
3. A mixture of two liquids showing positive deviation from Raoult's law with 
total vapour pressure value greater than maximum value of either pure solvent.
4. A mixture of two liquids showing negative deviation from Raoult’s law a 
minimum value less than either individual value
In our studies, the binary solvent mixtures used are acetone/methanol and 
dichloromethane/acetone both deviate from Raoult’s law. Since both the solvents show 
deviations from Raoult’s law, the partial pressures can vary linearly with mole fraction; 
hence applicability of Henry’s law can be appropriate. In order to apply Henry’s law to 
any volatile solute-solvent or non-volatile solute-solvent combinations, vapour-liquid 
phase equilibrium or chemical potential measurements are required, respectively. Since 
determination of these properties were beyond the scope of this research concepts 
relating to Henry’s law or Raoult’s are discussed in theoretical perspective only. 
However, there is a strong relationship between intermolecular interactions and vapour 
pressure and will be utilized to predict any anomalous behaviour.
Acetone is a solvent for felodipine and a non-solvent for PVP, whereas methanol is a
31solvent for both. Methanol is a polar protic solvent or amphiprotic hydroxylic solvent, 
that is, it can act as a proton donor (involving hydrogen from the hydroxyl group) and 
can be an electron pair donor (involving oxygen of hydroxyl group). Moreover, in protic 
solvents any solute that could form intramolecular H-bonding or self-association will be 
dissociated.185,186 Acetone is a polar aprotic solvent or dipolar aprotic solvent,31 that is, 
it acts as a proton acceptor and the carbonyl group is involved in this process. It 
interacts with methanol (MeOH) and can also interact with felodipine, but not with 
p y p  187 jn acetone/methanol BSM, methanol self-association could be inhibited through 
acetone H-bonding.
DCM is a solvent for felodipine and PVP, whereas acetone is a solvent for felodipine 
but non-solvent for PVP. Dichloromethane is a low polar but highly polarisable solvent 
(Table 4 .1).31 Due to the electronegativity of chlorine in DCM, it can interact with 
felodipine but with PVP to be explored.
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4.4.4 Acetone/Methanol BSM : Molecular Interpretation o f RaouWs Law
Since intermolecular (H-bonding) interactions o f methanol-acetone are weaker than 
methanol-methanol (H-bonding) interactions, the binary mixture will have reduced 
vapour pressure and hence the methanol evaporation from BSM is increased.
Condition: Methanol... Acetone < Methanol ...Methanol (MeOH Evaporation Fast)
Solids ...Methanol> Methanol ...Acetone (MeOH Evaporation Retarded)
Moreover methanol-acetone (H-bonding) interactions are greater than non-interacting 
acetone-acetone molecules; hence acetone evaporation from BSM or any interacting 
species will be retarded.
Condition: Methanol ...Acetone > Acetone ...Acetone (Acetone Evaporation Slow)
Solids...Acetone = Methanol...Acetone (No Effect)
4.4.5 DCM/Acetone BSM: Molecular Interpretation o f RaouWs Law
Ketones are hydrogen-bond acceptors and are not usually hydrogen-bond donors, hence 
cannot hydrogen-bond to itself or "self-associate".
Hydrogen bonds exist in polar molecules where hydrogen is directly bonded to a 
strongly electronegative element such as F, O or N. In dichloromethane, hydrogen is 
bonded to the carbon atom, which is not considered to be a strongly electronegative 
element. Thus, we would not anticipate hydrogen bonding or self-association in this 
molecule. However, dipole-dipole interactions are reported for acetone...acetone and 
DCM...DCM molecules.188
When DCM is added to acetone, dipole interactions are induced between DCM and 
acetone. At low temperatures (in this study 30 °C), a greater proportion of DCM and 
acetone molecules are interacting. Hence, there is no distinction between DCM-acetone 
interactions and acetone-acetone interactions. Consequently, the rate of acetone 
evaporation from this BSM should not change. Since PVP is not soluble in acetone any 
solid-acetone interaction is attributed to acetone-felodipine intermolecular interactions.
Condition: DCM...Acetone = Acetone...Acetone (No Change)
Felodipine ...Acetone > DCM...Acetone (Acetone Evaporation Retarded)
DCM-DCM interactions are weaker compared to DCM-acetone interactions; hence we 
anticipate that dichloromethane evaporation from this BSM should be retarded relative 
to the rate in pure sovent.
Condition: DCM...Acetone > DCM...DCM (Evaporation is Retarded)
Solids...DCM > DCM...Acetone (DCMEvaporation Retarded)
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The scenario is quite different at higher temperatures (in this study 40 °C and 50 °C), 
the proportion of DCM and acetone molecules interacting are reduced. Hence, DCM- 
acetone interactions are weaker compared to acetone-acetone interactions; consequently 
the rate o f acetone evaporation from this BSM should be increased. Felodipine-acetone 
interactions are stronger than DCM-acetone interactions; subsequently the rate of 
acetone evaporation from this BSM should be retarded.
Condition: DCM...Acetone < Acetone ...Acetone (Acetone Evaporation Fast)
Felodipine...Acetone > DCM...Acetone (Acetone Evaporation Retarded)
At higher temperatures, DCM-acetone interactions are similar compared to DCM-DCM 
dipole interactions; hence the rate of dichloromethane evaporation from this BSM 
should not change. Solids-DCM interactions are stronger than DCM-acetone 
interactions; hence the rate of dichloromethane evaporation from this BSM should be 
retarded.
Condition: DCM...Acetone = DCM...DCM (No Effect)
Solids...DCM  > DCM...Acetone (DCMEvaporation Retarded)
In order to verily these interpretations, pure solvents, binary solvent mixtures 
(acetone/methanol, DCM/acetone), 100% drug, 100% polymer and various drug loaded 
samples in binary solvent mixtures were studied. The results of these measurements for 
both the binary solvent mixtures are shown in Figure 4.9A-D. The experimental results 
are consistent with theoretical predictions and will be used to understand the formation 
of solid dispersion, molecular interactions, phase behaviour and final product 
characteristics.
4.4.6 tjQ Measurements -  Kinetics o f  solvent evaporation and film  formation
With FTIR, it was possible to simultaneously monitor the rate of evaporation of the 
solvents and the formation of felodipine/PVP solid dispersions. Comparisons of 
measurement results at three different temperatures for various samples are shown in 
Figure 4.10 and Figure 4.11. Error bars are the standard deviation from 5 repeated 
measurements and indicate reproducibility. The binary solvent mixtures (BSM) studied 
were acetone/methanol and dichloromethane/acetone.
a. Binary Solvent Mixture
From Figure 4.10A it can readily be seen that temperature has a drastic impact on the 
rate of evaporation of methanol from the binary solvent mixture as expected. The rate of 
evaporation of methanol from the binary solvent mixtures is increased as the
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temperature is raised. When the solids are incorporated the scenario is slightly different, 
that is, methanol evaporation rates at higher temperatures (50 °C) are different from 
those at 30 °C (Figure 4.10A). This is the trend irrespective of nature of solids. 
Interestingly, evaporation of methanol from a pure solvent mixture is thus different in 
the presence of solids. There is clear retardation when solids are incorporated. Statistical 
analysis using ANOVA (F and P values) shown in Table 4.3A confirms this 
observation, that is, temperature and sample composition have a significant effect on the 
methanol evaporation rates at a 95% confidence interval. In order to determine between 
temperatures and within sample variations, least significant difference (LSD) tests were 
carried out and the results are shown in Table 4.4A. LSD results showed that within 
sample variations are not probably significant at the 95% confidence level. That is, the 
retardation of methanol from 100% polymer or 100% drug or 20%, 50%, 80% drug 
loaded samples are not statistically significant.
Results from the fio measurements of DCM/acetone binary solvent mixture, shown in 
Figure 4.11 A, indicate that the DCM evaporation from the binary solvent mixture is 
retarded when the solids are incorporated except 50% drug loaded samples. This is more 
pronounced at 40 °C and 50 °C but no different at 30 °C. Moreover, the evaporation of 
DCM is slower in low drug loaded samples than the high drug loaded samples which 
indicate that the rate of evaporation of DCM from these systems is different. This is 
supported from the statistical results. ANOVA results (Table 4.3B) indicate that both 
temperature and samples are significantly different at the 95% confidence interval. The 
least significant differences indicate that the rate of evaporation of DCM at 40 °C and 
50 °C are different to 30 °C but between them, the differences are probably statistically 
insignificant. DCM evaporation rate (Table 4.4B) is significantly retarded when the 
solids are incorporated. However, the evaporation of DCM from binary mixture and 
50% drug loading (DL) samples are no different. As with peak height measurements, 
the retardation of DCM from high drug loaded (50%, 80% and 100%) samples are 
lower than the low drug loaded (0% and 20%) samples. However within high and low 
drug loadings there are no significant difference at the statistical level.
From Figure 4.10D, it is obvious that the temperature has a significant effect on the rate 
of evaporation of acetone in the presence of methanol. The evaporation o f acetone from 
all the samples (including solids) is increased as the temperature is raised. Interestingly, 
the rate of evaporation of acetone from binary solvent mixture is not significantly
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changed when the solids are incorporated. The t\o results and the aforementioned 
interpretation is supported from ANOVA results (F and P values) and LSD results 
shown in Tables 4.3A and 4.4A, respectively. The results confirm that temperature has a 
significant effect on the evaporation, that is, increase in temperature accelerates the 
acetone evaporation. But acetone evaporation from mixture of binary solvent mixture is 
not altered when solids are present.
The ?io results for the acetone evaporation from the DCM/acetone binary solvent 
mixtures can be seen in Figure 4.1 ID. An increase in the temperature increases the 
DCM solvent evaporation. The evaporation of acetone from the binary solvent mixture 
at 30 °C is statistically no different in the presence of solids; however, DCM 
evaporation in the presence of solids is increased at higher temperatures, in this study, 
40 °C and 50 °C. Moreover, from the t \o results it can be seen that the retardation in 
acetone evaporation is more pronounced in high polymer loaded samples than high drug 
loaded samples. That is, the evaporation of acetone is comparatively quicker from the 
high drug loaded samples than low drug loaded samples. ANOVA results (Table 4.3B) 
indicate that the evaporation rate of acetone is influenced by temperature and nature of 
samples. Results from the least significant differences indicate that 30 °C is different to 
40 °C and 50 °C but between 40 °C and 50 °C there are no significant differences. 
Acetone evaporation (Table 4.4B) is significantly retarded when the solids are 
incorporated. Interestingly, the retardation of acetone from high drug loaded (50%, 80% 
and 100%) samples are lower than the low drug loaded (0% and 20%) samples. 
However within high and low drug loadings there are no significant difference at the 
statistical level. These results are in line with the peak height measurements.
b. Film Formation o f  Felodipine
The temperature has a significant influence on the rate of film formation of felodipine, 
as shown in Figure 4.10B. That is, raising the temperature sequentially increases the 
film formation rate irrespective of 100% drug or polymer loaded samples. Interestingly, 
the film formation rate of 100% drug loaded samples is no different with polymer 
loaded samples. However, there are differences in the final products, which will be 
discussed in the following sections (i.e. molecular interactions). This interpretation is 
further strengthened by analysing the results from the ANOVA test (F and P values), 
Table 4.3A. There are significant differences with temperature and samples at the 
statistical level. Furthermore, LSD (Table 4.4A) indicates that there are significant
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differences between the rates at different temperatures at the statistical level. LSD 
indicates that the rate of formation of 20% drug loaded sample is significantly slower 
than the 80% and 100% felodipine/PVP concentrations. But within 80% and 100% the 
formation rates are not statistically significant.
The t\o results for the rate of formation of felodipine when cast from DCM/acetone are 
shown in Figure 4.1 IB and could be readily inferred that, as there is increase in the 
temperature, the rate of formation of felodipine is increased. This interpretation is true 
with 100%, 80% and 20% drug loaded samples but for the 50% drug loaded sample 
there is no change. ANOVA results shown in Table 4.3B indicate that there is a 
significant difference between temperature and sample composition at the 95% 
confidence interval. LSD results (Table 4.4B) indicate that the rate of formation of 
felodipine at 30 °C is slow when compared to 40 °C and 50 °C but no difference 
between 40 °C and 50 °C. Also, the behaviour of 50% drug loaded samples is different 
to 20%, 80% and 100% but between these loadings there is no difference at the 
statistical level.
c. Film Formation o f  Polyvinylpyrrolidone
The rate of PVP film formation from the acetone/methanol binary solvent mixture is 
shown in Figure 4 .10C. Temperature has a remarkable effect on the film formation rate 
of PVP when there is high drug loading; raising the temperature increases the film 
formation rate for these samples systematically. However, with 20% drug loading, the 
rate of film formation at 50 °C is different to 30 °C and 40 °C, that is, the film 
formation time is reduced at 50 °C. Apart from the temperature differences, rate of film 
formation of pure polymer (100% polymer) is not altered when in the presence of drug 
loading. Furthermore, ANOVA F and P values Table 4.3A, imply that there are 
significant differences between temperatures and samples at the 95% confidence level. 
In addition, LSD results (Table 4.4A) indicate that the rates of film formation of PVP at 
the various temperatures are significantly different, that is, raising the temperature 
increases the film formation rate. The rate of formation of PVP from 50% drug loaded 
sample is faster than 20% drug loaded ones, but not with other samples.
From Figure 4.11C (tw results) it could be seen that the rate of formation of PVP is not 
influenced by the temperature for the 0% drug loaded samples. For the 20% DL the 
PVP formation is influenced at 50 °C. For the other samples, that is high drug loadings 
the effect of temperature is systematic, that is, as there is increase in the temperature
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there is increase in the rate o f PVP formation. ANOVA results shown in Table 4.3B 
indicate that the differences between the temperature and samples are statistically 
significant at the 95% confidence interval. Least Significant Differences shown in Table 
4.4B, indicate that kinetics at 30 °C are different to those at 40 °C and 50 °C, but, 
between 40 °C and 50 °C there are no differences. Interestingly, LSD results indicate 
that any difference within samples only occurs with the 50% drug loaded samples and 
any differences with other samples are not statistically significant.
4.4.7 Residual solvents
To assess the sensitivity, reproducibility and validity of FTIR measurements, TG-MS 
analysis was carried out to quantify the amount of residual solvents in the binary solvent 
mixtures, 100% felodipine cast from acetone/methanol (FAM) and 100% PVP cast from 
acetone/methanol (PAM) samples. Typical TG-MS ion curves and thermograms are 
shown in Figures 4.12 to 4.15. The ion curve results show the evaporation of acetone 
and methanol from various samples. The resulting TG-MS curves are found to be 
strikingly similar to FTIR kinetic profile curves (cf. Figure 4.4). That is, acetone 
evaporates first followed by methanol.
From the FTIR (Figure 4.2) the solvents were found to be completely evaporated after 
~2 minutes at 30 °C. The TG-MS data (Table 4.5) show more residual solvents in the 
studied systems (BSM 4%, FAM 8%, PAM 7%) after 14 minutes at 30 °C. The acetone 
and methanol from the BSM system as found to be completely evaporated after 20 
minutes at 32 °C, whilst 2-3 % remained in the FAM or PAM samples. This % was 
believed to be within the error and was further confirmed by studying another 
time/temperature interval of 72 minutes/240 °C where the % remaining is equivalent to 
the % remaining at 20 minutes/32 °C. If these were residual solvents, at the high 
temperature, the remaining solvent should have been removed. These results indicate 
that FTIR analysis can be applied to monitor the solvent vaporization in real time with 
good measurement sensitivity and reproducibility.
4.4.8 Molecular Interactions
FTIR is a powerful tool to study molecular interactions in any form (solid, liquid or gas)
and of any type (H-bonding, Vander Waal’s or pi interactions, etc). In order to obtain
further evidence of the possible interactions, spectral frequency shifts were monitored.
Table 4.6 shows the characteristic peaks for starting materials that can be exploited to
monitor intermolecular interactions. These ideas will be utilized to study solvent-
solvent, solvent-solid interactions by monitoring the solvent induced frequency shifts
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(SIFS) and solid-solid interactions from peak shifts of the pure material (cast and solid 
dispersion). In infrared spectroscopy, the NH, OH and C=0 bond absorptions and their 
molecular vibrations are usually very strong.189 Moreover, their peak positions or 
intensities are specific and sensitive to the infrared local environment. Thus, any 
alterations in peak positions due to inter and intramolecular interactions are 
representative.
Table 4.5. Residual solvents for various samples
Temperature Time BSM FAM PAM
RI R2 R3 RI R2 R3 RI R2 R3
27 °C 5 min 60 64 62 
62% ± 2
63 59 
60% ± 3
58 66 63 
63% ± 4
59
30 °C 14 min 0.5 8 4 
4% ± 4
11 6
8% ± 3
7 10 6
7% ± 2
6
32 °C 20 min 0.0 0.3 0.1 
0.1% ±0.2
6 6
6% ± 0
6 8 6
7% ± 1
6
240 °C 72 min -NA- 5 55% ± 0
5 8 5
6% ± 2
5
a. Solvent-solvent interactions
The spectra recorded during the initial stages of the experiment are dominated by the 
solvents: spectral signatures confirm this. Any frequency shifts during this stage can be 
attributed to solvent-solvent interactions. In the acetone/methanol binary solvent 
mixture, methanol acts as a proton donor and acetone acts as a proton acceptor. This can 
be shown from the acetone carbonyl band which normally appears at 1711 cm '1 but in 
the presence of methanol the carbonyl band is broadened and found to shift to lower 
wavenumbers (1707 cm '1), Table 4.7. These changes can be attributed to intermolecular 
hydrogen bonding (H-bonding) between methanol and acetone.
In a DCM/acetone binary solvent mixture, the acetone carbonyl peak appears close to 
the unperturbed value which is 1711 cm"1 (but peak shape is perturbed). Moreover, there 
is increase in the peak intensity and narrowing of the peak compared to the pure acetone 
carbonyl peak. Also, in DCM, the V(ch> is found to shift by 5 cm '1 to a higher peak 
position, together with a simultaneous change in the DCM 6(ch) vibrations. The
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observed high frequency shift190 and narrowing of acetone carbonyl peak191 is 
attributable to induced dipole-induced dipole or dipolar interactions between DCM and 
acetone (Figure 4.16 and Table 4.7).
Pure Acetone
Acetone from acetone/methanol 
Acetone from DCM/acetone
0 .20 -
0.15cc
coo
0 .10-
0 .05 -
0 .00 ,
1800 1750 1700 1650 1600
Vfevenurrters (cm-1)
Figure 4.16. Solvent-solvent interactions
b. Solvent-Solid interactions
In order to understand more about nature of interactions between solvents and solids, 
ternary mixtures (that is, 100% drug or 100% polymer cast from acetone/methanol or 
DCM/acetone) were studied in detail. As the intensities of solvent bands decrease, there 
is an increase in the intensity of either the drug or polymer bands. At this stage, any 
frequency shifts can be ascribed to solvent-solid interactions (Table 4.8). In the 
acetone/methanol binary solvent mixture, acetone evaporated rapidly (cf. Oo results). 
From peak height measurements and ANOVA it is inferred that acetone does not 
interact with solids. This statement is supported by tracing the spectral changes and 
there is no significant changes observed with the acetone carbonyl peak. In addition, 
acetone is more volatile than methanol and evaporates rapidly before it can interact with 
the solids (cf. Oo acetone results Figure 4.10D).
Now, any shift in the frequency of drug or polymer bands (in acetone/methanol BSM) 
indicates that methanol is interacting with the solid and is attributable to methanol-solid 
interactions. Since methanol is a polar protic solvent or proton donor, it can interact 
with proton acceptors like acetone, felodipine and PVP through H-bonding. Felodipine 
is known to interact with methanol' through hydrogen bonding and this is evident from 
the ethyl ester carbonyl band appearing at 1680 cm'1 (in felodipine starting material 
ethyl ester carbonyl band appears at 1686 cm'1) during film formation, indicating a 
solvent-induced frequency shift. Formation of intermolecular H-bonds retards the
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evaporation rate of methanol, compared to the binary solvent mixture (absence of 
solids) and is evident from the /jo measurements. PVP can also interact with methanol 
through the formation of intermolecular hydrogen bonds. The carbonyl peak in the PVP 
starting material appears around 1654 cm'1. When PVP is cast from the acetone/MeOH 
binary mixture there is 4 cm'1 shift to lower wavenumber and the carbonyl peak appears 
at 1650 cm'1. This indicates that methanol and PVP can also interact, the evaporation of 
methanol is retarded when compared to the rate in a binary solvent mixture, which 
agrees well with th e / jo results.
Results from the peak height measurements and ANOVA indicate that the methanol 
evaporation is retarded when solids are incorporated. Within sample variations (that is, 
different felodipine/PVP concentrations) are insignificant, which means drug and 
polymer interact with methanol to the same extent and LSD supports this. This 
retardation can be attributed to the aforementioned molecular interactions. From these 
findings, it is concluded that although methanol interacts with the felodipine and PVP, 
there is no evidence for acetone to interact with the solids. Besides, to support this 
conclusion kinetics and molecular interactions of felodipine and PVP in the second 
binary solvent mixture (DCM/acetone) was studied in detail and will be discussed 
further.
In the DCM/acetone binary solvent mixture, when felodipine is detected it is found to 
interact with DCM and acetone at different stages. This can be substantiated by further 
considering the peak position changes of both NH and C=0 stretching of felodipine and 
acetone, respectively. When the NH stretching peak of felodipine appears at 3344 cm’1 
the corresponding carbonyl peak of acetone appears around 1703 cm '1. The 8 cm’1 shift 
of v(Co)to lower wavenumber is indicative that felodipine interacts with acetone through 
the formation of H-bonds. Also before there is complete evaporation of acetone and 
DCM, the felodipine NH stretching peaks, fluctuate markedly and appear between 3351 
cm'1 to 3344 cm '1. This could be due to interaction of felodipine with both the solvents. 
The main objective for studying the second BSM is to better understand whether 
acetone interacts with felodipine. With the peak position changes, t\o, MCR and 
statistical data analytical tools, we are quite happy to conclude that there is clear 
retardation in acetone evaporation when in DCM/acetone BSM but there is no 
retardation of acetone with solids in the acetone/methanol BSM.
As previously discussed PVP is insoluble in acetone and hence there could be no 
interaction. Any retardation in acetone evaporation indicates only physical effects like
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viscosity, etc. However, PVP interacts with DCM. Since dichloromethane is a 
polarisable solvent, it interacts with PVP through strong dipole-dipole or dipolar 
interactions. These interactions change the conformation of PVP wherein there is shift 
o f carbonyl group to 1662 cm'^cf. the starting material where it appears at 1654 cm'1). 
Also evidenced from the DCM peak shifts V(ch) 3049 cm '1 (due to N+=C-CT 
reorientation of PVP and interaction with C l'in  DCM) and 6(cci) 697 cm '1. The PVP- 
solvent interactions thus change the conformation of the polymeric matrices and can 
influence the incorporation of the drug or formation of solid dispersions. These will be 
discussed in Chapter 7 “The Application of Vibrational Spectroscopy to Solid 
Dispersions: Final Product Characteristics”. Moreover, PVP-felodipine intermolecular 
interactions, drying kinetics and distribution, etc will also be discussed.
4.5 Conclusion
Variable temperature ATR-FTIR can be successfully used to monitor the formation of 
solid dispersions in situ and is a suitable technique to study evaporation rates on this 
time scale (seconds). Detailed kinetic information is obtainable; t\o (the time taken for 
solvent concentration to drop to 10% of its original value) and tgo (the time taken for the 
solid concentration to rise to 90% of its final value) are suitable parameters. The use of 
the tso parameter was found to be less useful as it did not allow us to distinguish 
between systems. MCR has been successfully used to extract t\o values for acetone. 
Raising the temperature increases the rates of solvent evaporation. Acetone evaporates 
fastest causing an increase in the methanol proportion in the sampling zone. 
Subsequently, methanol evaporates, leaving the felodipine/PVP solid dispersions. The 
rate of acetone evaporation is independent of the presence of solids indicating little or 
no interaction with PVP or felodipine. However, there is clear evidence of interaction of 
methanol with solids. The rate of evaporation of methanol is significantly retarded when 
the solids are incorporated. This indicates interaction o f methanol with the solids, most 
probably by hydrogen bonding.
Moreover, monitoring the peak shifts, peak shapes and widths were very useful to track 
the molecular interactions between solids and solvents successfully. There is no 
evidence for molecular interactions of solids with acetone (in acetone/methanol BSM) 
but there are clear indications that both felodipine and PVP interact with methanol. 
Drug loading and temperature affect the drying rate that is, increasing the temperature 
and lowering the drug loading increases the drying rate of solids from acetone/methanol 
BSM.
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The investigated conditions could mimic the formation and preparation of solid 
dispersions, behaviour of different components in solid dispersions, association through 
intermolecular interactions and phase behaviour. Moreover, these results would be a 
starting point to better understand the distribution o f various components in solid 
dispersions, phase transition, phase separation resulting to physical, thermal and 
chemical instabilities. The molecular interpretation o f Raoulf s law, monitoring spectral 
peak shifts and TG-MS analysis indicate that t\o data analysis can be a promising 
approach to extract kinetic information.
Table 4.6. Characteristic peaks used to interpret molecular interactions
Acetone Methanol DCM Felodipine PVP
VNH - - - 3364 cm"1 -
Vanti(CH) - - 3054 cm'1 - -
V sym(CH) - - - -
OlluV 1711 cm’1 1694 cm '1 
1686 cm '1
1657 cm '1
5 c h - - 731 cm '1 - -
Table 4.7. Solvent-solvent interactions (note: NA-Not Applicable)
Acetone Methanol DCM
Acetone (vc=o) and 1711 cm '1 1707 cm '1 1711cm '1
Full width at half height 15 cm'1 20 cm '1 13 cm '1
DCM ( v c h ,  § c h ) 3059/733 cm'1 -NA- 3054/731 cm '1
Table 4.8. Solvent-solid interactions (note: NI-No Interactions)
Acetone/Methanol BSM DCM/Acetone BSM
Acetone Methanol DCM Acetone
Felodipine ( v n h ) -NI- 3337 cm '1 3351 cm'1 3344 cm '1
PVP (voo) -NI- 1650 cm '1 1662 cm'1 -NA-
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C h a p t e r  5. 
E v a l u a t io n  o f  Im a g e  P r o c e s s in g  T o o l s  f o r  M id - 
In f r a r e d  Im a g in g
5.1 Introduction
FTIR imaging is a relatively new technique which provides spectral and spatial 
information for microscopic chemical characterisations.109 With the imaging 
investigations, apart from the conventional spectroscopic benefits, the distribution and
107 113location of the individual components within the mixture can be established. * These 
advancements enhance the chemical characterization of the samples on a microscopic
2 7 113scale including its morphological form (typically polymorphs and hydrates). ’ ’ 
Thousands of infrared spectra with near-diffraction limited spatial resolution and 
moderate spectral resolution can be acquired in minutes depending on the 
instrumentation type.1
In recent years, it has been shown that FTIR-reflectance imaging can be applied to a 
multitude o f fields from biomedical applications,192'194 single cells,195’196 polymer 
research,107’118,121,197,197'203 agricultural industries204,205 and identification of artistic 
materials.206 Real time analysis of complex systems involving fast infrared imaging has 
also been reported.107 Although, FTIR imaging has found immense applications in the 
aforementioned industries, in the pharmaceutical field except for a few 
publications121,207 the widely used sampling technique is ATR imaging.173,208'211 Those 
few publications were made at the early stages of the infrared imaging applications. The 
main reason could be the complexity of pharmaceutical materials. However, considering 
the widespread use of mid-infrared imaging in the single cell and biomedical fields 
(considerably complex),212 understanding and developing data analysis protocols should 
benefit the pharmaceutical industries. This work presents the application of 
chemometric approaches to reduce and analyse large amounts of data from FTIR 
chemical images acquired from pharmaceutical materials.
5.2 Materials and Methods
Three samples with different compositional distributions were studied. Model system I, 
a high contrast sample (chemical contrast) contains cinnarizine (CIN) cast , from 
dichloromethane and felodipine (FEL) cast from methanol (4% w/v), showing the 
interface. Model system I serves as a known phase separated system. It was selected to 
optimise the data pre-processing and data processing procedures. The optimised data 
analytical tools were extended to study two other systems. Model system II or low
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contrast sample (chemical contrast) contains felodipine/PVP solid dispersion spray 
coated from acetone/methanol (4% w/v) and then stored in a dessicator which yields a 
system that is intimately mixed.49,91 Model system II serves as a homogeneous system. 
The other sample is model system III, a medium contrast sample (chemical contrast) 
containing felodipine and PVP spray coated from dichloromethane and acetone (4% 
w/v). The prepared sample was stored at high relative humidity (98%) for a period of 12 
hours to induce phase separation and will be discussed in detail in Section 5.6.3. Model 
system III serves as a system of unknown distribution.
These three optical/brightfield and total intensity chemical images samples are shown in 
Figure 5.1. A Varian 620 FTIR imaging instrument in reflection-absorption mode was 
used for data collection with a focal plane array (FPA) of 64 x 64 mercury-cadmium- 
telluride detectors. This provided an image size of -350 pm x 350 pm (i.e. 64 x 5.5 
pm). Spectra were collected averaging 64 scans at a 4 cm"1 spectral resolution in the 
4000-920 cm"1 spectral range. The acquired chemical images were manipulated using 
Resolution pro (Varian system in-built software) to perform peak height or univariate 
analysis. Then the images were converted to .spc files to be studied in Isys 50 (chemical 
image software) and MCR version 2.1 (Courtesy: Thomas Hancewicz, Unilever 
ltd) 140>178’179
5.3 “ Understanding the Raw Data
Although much literature has been published, chemical imaging is still in its nascent 
stage; especially to extract useful information from the raw intensity image. That is, 
artefacts can be introduced at different stages of chemical image collection. For 
example, the sampling mode or measurement geometry was found to have a remarkable 
effect on the data quality as well as on the data purity or contamination.213 Here the 
contamination refers to optical artefacts or dispersion artefacts.214 Except for the 
transmission and attenuated total reflectance mode, other methods like reflection- 
absorption, grazing angle or diffuse reflection were found to be seriously influenced by 
the particle size; especially when the wavelength of radiation and the particle size are 
similar in size, leading to well known Mie-type scattering issues.212"214 These spectral 
distortions can be corrected using a modified version of extended multiplicative signal 
correction algorithms (RMieS-EMSC)215,216 That said, the issues are a major concern 
when materials with varied particle size, such as biological materials containing 
nucleus, protein and lipids in a single substrate, are studied. In the pharmaceutical 
industry, although variations in particle size are present, these would not pose serious
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issues because the particle size of the pharmaceutical products is either smaller or larger 
in size than the wavelength of radiation. In the following section, methods to tackle 
these issues are discussed.
Model systems Brightfield images Total intensity images
Model system I or High 
contrast sample
Model system II or Low 
contrast sample
• '%s*r
Model system III or 
Medium contrast 
sample
Figure 5.1. Brightfield and total intensity images of the model systems 
studied
Spectra from the chemical images vary significantly in intensity and shape.106 The so- 
called hyperspectral images contain a wealth of information both in quality and 
quantity. Hence it is prerequisite to reduce the large amount of data before proceeding 
to interpret the results. It is then possible to separate genuine chemical effects from the 
optical artefacts. For example, in the solid dispersion the things to be understood and 
interpreted are drug bands, polymer bands, drug + polymer mixture effects or other 
interactions (H-bonded, non-polar interacting mixtures, etc.), residual solvent, scattering 
or dispersion artefacts, optical artefacts like dead pixels or saturated pixels, baseline 
variations or thickness or pathlength variations and/or atmospheric interferences (water 
vapour or carbon dioxide). It is evident that the total intensity images acquired mostly
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features physical variations rather than chemical signatures.104,136,217 Understanding 
these would help in formulating better data analysis procedures.
5.4 Data Pre-processing
The first step in the data pre-processing is to truncate to the region of interest. This 
enhances the separation of the components as well as reducing the storage memory. The 
selected bands should be non-interacting, non-saturating and ideally not influenced by 
optical artefacts.195,196 The regions of interest used in this study are shown in Table 5.1. 
Moreover the regions of interest selected are free from the atmospheric interferences 
like water vapour and carbon dioxide.
Table 5.1. Regions of interest
Samples Region studied or truncated
Model system I 2850 to 2780 cm '1
Model system II 1125 to 1090 cm'1
Model system III 1125 to 1090 cm '1
In the model systems selected, the commonly encountered optical artefacts were
saturated or anomalous pixels, baseline variations and thickness variations. The spikes,
218anomalous, dead or saturated pixels, if present, are converted as Not-a-number (NaN) 
and then spectral masking is applied. In order to facilitate a better analysis and 
interpretation, absorbance values above ~1.5 are masked as NaN’s.
The baseline variations were removed by performing a second derivatisation on each 
spectrum/pixel.136 In order to correct for thickness variations, the derivatised spectra 
was scaled with respect to the most intense peak in the spectrum. This normalisation 
scales spectra to a maximum "intensity" of 1 and a minimum of 0. Minimal 
preprocessing is preferred,136 but if artefacts are significant new algorithms are being 
developed to handle these problems effectively.105,214'216,219
After pre-processing the data, the key question then to be answered is to determine how 
many components contribute to the signal. To achieve this, spectral variations need to 
be understood. The spectral variations can be important to understand the morphology, 
the shape and size o f features and the presence of molecular interactions.106 In order to 
understand molecular interactions at least at the optimisation level, a typical sample 
prepared by casting the felodipine/PVP sample. (50pl) using a Finnpipette was used. For 
model system II, felodipine/PVP is cast from acetone/methanol while for model system 
III; felodipine/PVP is cast from dichloromethane/acetone. The peak positions, peak
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widths and the intensities were of good quality to be representative for any molecular 
interactions.
5.5 Data Processing
The pre-processed data must be of sufficiently good quality to extract chemically 
significant information. There are several potentially useful data processing methods 
available from classification or clustering techniques to pixelwise data extraction 
methods. However, the types of data processing procedures depend upon the objective 
in extracting relevant information from the chemical images. The following four data 
processing procedures will be critically evaluated for their usefulness in identifying the 
components of interest in the hyperspectral data cube.
(a). Univariate analysis : Peak Height Measurements (PHM)
(b). Supervised Pattern recognition techniques : Compare Correlation (CC)
(c). Exploratory data analysis : Principal Component Analysis (PCA)
(d). Image Resolution Methods : Multivariate Curve Resolution (MCR)
When the raw image data for model system I in any type (full or truncated) were 
analysed using univariate or multivariate tools, erroneous results were obtained (this 
will be discussed in detail in the following sections)'. Moreover, this was also the same 
case when pre-processed data of full spectral range (4000 to 920 cm -1) were considered 
(data not shown). The scenario was different when the data was truncated to the region 
of interest (2850 to 2780 cm-1) followed by pre-processing steps and then the 
processing steps were applied. That is, optical artefacts like thickness variations and 
particle size are separated and any observed variation is now due only to chemical 
properties.
5.6 Results and Discussion
5.6.1 Model system I  or High Contrast sample or Pharmaceutical Alloys
Model system I had strips of material with known composition (cinnarizine and
felodipine) right half is pure felodipine, but the left half is a mixture of cinnarizine and
felodipine. Exploratory investigation of the spectra, that is, V(ch) 2807 cm’1, indicated by
an arrow mark in Figure 5.2, revealed the presence of three chemically distinct regions.
That is, model system I contains regions where there is pure felodipine, felodipine rich
and cinnarizine rich mixture regions. Images were generated using discrete peaks at
2807 cm’1 and 1099 cm’1 to evaluate the distribution of these regions using peak height
measurements (Figure 5.3A). The regions in red indicate high concentration o f
80
components while blue indicates low or zero concentration. Figure 5.3A, shows that 
both the components are present at the same spatial co-ordinates. That is, the univariate 
measurements were successful in extracting mixed regions of cinnarizine and 
felodipine; but failed to extract the distribution o f pure felodipine layer, because the 
image has mixed regions of cinnarizine and felodipine of high absorbance. The 
distribution images extracted using univariate analysis of the raw data is not pre- 
processed to remove any previously mentioned optical artefacts. Typical spectrum of 
pure cinnarizine and felodipine are presented in Figure 5.3A under cross-validation. The 
results of univariate analysis will be used as a control to understand the impact of data 
pre-processing and data processing procedures.
From Figure 5.3B, the results of the compare correlation maps (extracted from the 
spectra of pure components) indicate high contrast between the two components, 
cinnarizine and felodipine. Here a correlation value of 0.99 to 0.80 (assigned red to 
yellow) indicates that the regions in the image belong to the reference product to which 
it is compared; whereas a correlation value less that 0.5 indicates the absence of 
similarity (assigned blue). The intermediate values would require cautious 
interpretation. From this, it is clear that there is a strong relationship between correlation 
coefficient value, distribution of components and concentration of analytes in the 
mixture. However, in order to have a better understanding of the compare correlation 
results, the "Histogram" is studied in detail. "Histogram" is a useful tool to study the 
distribution of various components within the mixture. "Histogram" analysis for model 
system I (Figure 5.3B, cross-validation) shows bi-modal or two different kinds of 
distribution. The results indicate that the model system I contains two components that 
are highly phase separated. Although the results from compare correlation maps and 
"Histogram" seem to be very interesting, the unavailability o f the pure spectrum for 
mixed felodipine shows the major limitations o f the supervised data analysis approach.
Before interpreting the distribution of various components within the processed images, 
the extracted pure components from PCA and MCR are analysed. Figure 5.4, shows the 
comparison of the results from univariate, PCA and MCR data analysis in the spectral 
range between 2850 cm'1 and 2750 cm'1. In all these data analyse the spectrum is second 
derivatised. From univariate analysis, three components are identified as; cinnarizine 
rich, felodipine rich, pure felodipine and are assigned the colours black, red and green, 
respectively. The respective spectra were collected from cinnarizine rich, felodipine rich 
and pure felodipine regions. The corresponding results in PCA analysis are labelled PC
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I, PC II and PC III whereas in MCR data analysis these are labelled MCR factor I, II 
and III, respectively. Strong correlation between the ‘spectra’ can be observed in the 
following spectral regions 2807 cm'1 for cinnarizine rich region (PCI and MCR1), 2820 
cm'V2790 cm '1 for felodipine rich region(PC2 and MCR2) and 2840 cm_1/2790 cm '1 for 
pure felodipine regions (PC3 and MCR3).
From the Figure 5.3C, the results of the principal component analysis are shown. The 
principal component corresponding to cinnarizine rich region shows 91% of the 
variance, the second principal component corresponding to felodipine rich region shows 
7% variance while third principal component (pure felodipine region) shows 0.6% of 
the variance. The first three principal components (PC’s) explain 98.6% of the total 
variance. Although, this does not account for more than 99%, the results from the 
PRESS plot, a cross-validation scheme220 to measure the descriptive ability of the PCA 
analysis is applied. The PRESS plot is generated by plotting predicted residual error of 
sum of squares versus number of principal components and the minimum value in the 
plot indicates the correct number of principal components to be predicted. PCA PRESS 
plot (Figure 5.3C) indicates that three principal components will account for all 
variability in this data set.
The results for model system I using MCR-ALS is shown in Figure 5.3D. Data analysis 
using MCR-ALS is based on hard or white modelling approach.221 That is, chemical 
knowledge o f the sample and the number of components within the system is well 
known. The Figure 5.3D shows the MCR distribution maps for cinnarizine rich, 
felodipine rich and pure felodipine regions. The cross validation scheme applied for 
MCR is the direct comparison of the extracted pure components with the real pure 
components. Moreover, from univariate and PCA analysis it is established that model 
system I contains three factors.
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Figure 5.2. Raw image data for model system I (Left) and Spectra from various 
regions (Right)
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As already mentioned the results from the univariate measurements and compare 
correlation needs careful interpretation and shows the need for the data pre-processing 
approaches. The results generated using PCA and MCR are in good agreement, reliable 
and meaningful. The results show that this simple model system consists of three 
components and is highly phase separated.
5.6.2 Model system II or Low Contrast sample
This model system of felodipine/PVP cast from acetone/methanol was studied to extend 
the data analysis in a way to better understand the optimisation tools. Moreover, a great 
deal of work in bulk and microscopic analysis of solid dispersions revealed that a drug
•  OR 00 0  •  r*dispersed in the polymeric material is in an amorphous state. ■ The disappearance of 
the NH stretching band at 3376 or 3337 cm'1 or appearance of the NH stretching peak at 
3292 cm '1 indicates the formation of solid dispersions.88 That said, the results from the 
unprocessed univariate analysis (Figure 5.5A) appear to be quite contradictory. Images 
were generated using discrete peaks at 2886 cm'1 and 1099 cm'1 to evaluate the 
distribution of PVP and felodipine using univariate or peak height measurements and 
Figure 5.5 A underlines to indicate significant separation of the components.
The raw data cube acquired was pre-processed in a similar way to that previously 
discussed (cf. pre-processing of model system I). The pre-processed data was then 
processed using chemometric data processing steps. The results from compare 
correlation are shown in Figure 5.5B. Moreover, comparing the correlation images of 
pure felodipine, pure PVP and a mixture shows that the intensity range is from 0.88 to
0.99. This indicates that the pure components and a felodipine/PVP mixture are highly 
correlated; offering a reliable qualitative indication that the components are uniformly 
distributed. Moreover, the "Histogram" (Figure 5.5B) fit a Gaussian like or unimodal 
distribution for the pure components. Hence, it can be concluded that the model system 
II is homogeneously distributed.
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U ni v ariate Analysis
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Figure 5.4. Comparison of 'Real' pure component spectra and 'Extracted' pure
components for Model system I
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Figure 5.6, shows the comparison of the results from univariate, PCA and MCR data 
analysis for model system II in the spectral range between 1125 cm '1 and 1090 cm '1. In 
all this data the spectra are second derivatised. From univariate analysis, two 
components are identified as; solid dispersion rich region and PVP rich region and are 
assigned colours red and blue, respectively. The corresponding results in PCA analysis 
are labelled PC I and PC II whereas in MCR data analysis these are labelled MCR 
factor I and II, respectively. Strong correlation between the ‘spectra’ can be observed in 
the following spectral regions 1099 cm'Vl 114 cm'1 for solid dispersion rich regions and 
1099 cm'Vl 116 cm '1 (shoulder peak) for PVP rich regions.
The results from PCA are shown in Figure 5.5C. The score images indicate that 99.6% 
of the total variability is explained with the first principal component (PC 1) or solid 
dispersion rich region, the second principal component (PC II) or PVP rich region 
explains 0.36% of the variability. The PRESS plot also shows that only two principal 
components are required to characterise the data.
The chemical knowledge of the sample and the number of components expected within 
the model system II is well known and predicted that the system contains two factors 
(solid dispersion and PVP rich regions). The distribution of the MCR factors are shown 
in Figure 5.5D. The obtained images matched well with the PCA results which gave us 
the confidence in predicting the results. Each of the compare correlation images look 
similar and resemble the image to PC 1 and MCR factor 1. The distribution o f each 
component cannot be precisely calculated if there is uniform distribution, at least with 
the' statistical pattern recognition methods like compare correlation. PCA is an 
exploratory approach and estimates concentration of analytes based on the global pixel 
variations whereas MCR estimates the concentration of each factors or analyte based on 
pixel to pixel variations.136 That is, the distribution of solid dispersions is dominant in 
the chemical image and only a few pixels indicate the presence of pure polymer.
The results from PCA and MCR are in good agreement and reveal that the 
felodipine/PVP solid dispersions cast from acetone/methanol are homogeneously 
distributed. This example clearly illustrates the need for data pre-processing and 
sophisticated data analytical tools to avoid misinterpretation when components are 
homogeneously distributed.
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Figure 5.6. Comparison of 'Real' pure component spectra and 'Extracted' pure
components for Model system II
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5.6.3 Model System III or Medium contrast sample
The data pre-processing and data processing procedures were then extended to 
felodipine/PVP solid dispersions cast from DCM/acetone binary solvent mixture, 
hereafter called model system III. The sample was stored at high relative humidity 
(98%) for a period of 12 hours and then studied. The raw data cube acquired was pre- 
processed in a similar way to that previously discussed (cf. pre-processing of model 
system I). Before interpreting the results it is worth detailing the storage conditions and 
their impact on the prepared solid dispersions. When a prepared solid dispersion is 
stored at an elevated relative humidity of 98% (using a saturated salt solution of 
potassium hydrogen sulphate), the absorbed moisture induces phase separation and
4R RR 0 1subsequent recrystallization of the drug.
Figure 5.7A shows images generated using peaks at V(nh) 3376 cm'1, V (ap2886 cm '1, 
and V(co) 1099 cm '1, to evaluate the distribution of (i) crystalline felodipine rich region 
(represented as drug rich) (ii) polymer rich regions with crystalline felodipine 
(represented as polymer rich) and (iii) homogeneous felodipine/PVP solid dispersion 
regions, respectively from the univariate measurements. A summary of the peaks used 
to describe the regions is presented in Table 5.2..
Table 5.2 Peak information used to interpret various regions in Model system III
Region Peaks
Drug Rich V(co) 1099 cm"1 (no V(ch)2886 cm '1 )
Polymer Rich V(nh)3372 cm '1 and V(co> 1099 cm '1
Solid Dispersion Rich V(ch>2886 cm '1 (no V(nh)3372 cm '1)
"Histogram" from compare correlation for the model system III shows that the sample 
contains at least three different components and the corresponding image planes for 
felodipine, PVP and solid dispersion are shown in Figure 5.7B.
Figure 5.8, shows the comparison of the results from univariate, PCA and MCR data 
analysis for model system III in the spectral range between 1125 cm’1 and 1090 cm '1. In 
all this data, the spectra are second derivatised. From univariate analysis, three 
components are identified as; solid dispersion rich region, PVP rich region, felodipine 
rich region and are assigned red, blue and green respectively. The corresponding results 
in PCA analysis are labelled PC I, PC II and PC III whereas in MCR data analysis these
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are labelled MCR factor I, MCR factor II and MCR factor III respectively. Strong 
correlation between the ‘spectra’ can be observed in the following spectral regions 1097 
cm'Vl 114 cm' 1 for solid dispersion rich regions, 1099 cm'Vl 120 cm ' 1 (shoulder peak) 
for PVP rich regions and 1097 cm'Vl 112 cm ' 1 for felodipine rich regions. Although 
there are slight deviations in the results the extracted components are mathematical 
results, the region selected is a narrow window; moreover these results are from a single 
pixel (that is, pixel to pixels variations are not included). Within these errors, the 
comparison between the results is satisfactorily accepted.
The PCA results are shown in Figure 5.7C, and the results indicate that 3 principal 
components are required to explain 98% of the total variability. The addition of two 
more PC’s would account for 99.6% of the variability. However, since the PRESS plot 
indicates that the sample contains only three PC’s, any further addition could lead to 
over-fitting. This gives us the confidence in deducing that only 3 PC’s are present 
within the sample.
The MCR results are shown in Figure 5.7D. Previous analysis o f the number of 
components (from PCA results) showed that model system III contains three factors. 
The areas obtained for factor I, factor II and factor III matched well with the PCA 
results which gave us the confidence in the results and clearly show that, under 
unsuitable storage conditions, phase separation can be induced in this system. Compare 
correlation shows similar polymer rich and felodipine/PVP solid dispersion images to 
those of PCA and MCR but the drug rich regions show poor agreement; probably 
indicating the requirement of an additional training data set.
5.7 Image visualisation tools
Once the data dimensionality is reduced and the distribution of components is 
established, the next step is to explore the spectral and spatial characteristics within the 
hyperspectral data.104 Moreover, summarizing the image results provides a useful means 
of understanding the complex data. This is imperative because we use vision to 
process193 approximately 75% of the incoming information and it is proven to be very 
useful in fields such as photography and histopathology. In this context, image 
enhancement tools are applied to better understand the distribution of various 
components within the model systems investigated.
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Figure 5.7. Comparison of chemometric data analytical tools in extracting distribution maps from the model system III
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Figure 5.8. Comparison of 'Real' pure component spectra and ’Extracted' pure
components for Model system III
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5.7.1 Red-Green-Blue (RGB) reconstruction
The RGB image is a composite image produced to enhance the visualising ability of the 
resulting images.104 RGB interpretation is a colour model in which three single channel 
images are created. It is created by overlaying each constituent distribution images 
derived from the principal component analysis and then assigning one of the three 
colours red, green or blue.223 These image enhancement tools help to better visualise the 
location of various components within the sample and also provide an insight into the 
uniformity and distribution (homogeneity or heterogeneity) of these constituents. . The 
RGB images are shown in Figure 5.9A, B and C for the model systems I, II and III, 
respectively.
5.7.2 Scatter plots with colour representation
The scatter plot with colour representation is one other visualisation tool that is used to 
extract the number of components present within the sample and their distribution. The 
results of PCA, scores or loadings, can be visualised by representing them in a scatter 
plot. The resulting scatter plot summarizes the relation or correlation between the 
loadings. Figure 5.10A, B and C are the scatter plots for the model systems I, II and III, 
respectively. The scatter plots represent the plot of principal component I (PC I) vs. 
principal component II (PC II). For example, in model system I, cinnarizine rich regions 
are found to be PC I and felodipine rich region is PC II. A set of data points in the 
scatter plot can be defined as an ellipse (shown in Figure 5.10A). While doing so the 
extracted individual features or regions from the principal component analysis can be 
marked by selecting one of the available colours (red, green, blue magenta, cyan, or 
yellow) 223 A different colour is used for each of the loadings and referenced in the 
table, so that different components and their distribution can be discriminated in the 
graph and in the image, respectively.
The graphical display of the variables can be used to identify whether different spectral 
features are related. If the two loadings are strongly related, then the data points form a 
systematic shape (e.g., a straight line or a clear curve). The straight line can be upwards 
meaning positive correlation between the loadings or negative correlation, if 
downwards. If the variables are not related, then the points form an irregular "cloud". 
The resulting composite image and scatter plot can be used to understand the 
distribution between the various components within the acquired image.
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5.7.3 RGB vs. Scatter plots
The RGB and scatter plots were produced after PCA analysis and are shown in Figure 
5.9 and 5.10, respectively. The resulting variables or the principal components were 
assigned specific colours, shown in Table 5.3. With model system I, cinnarizine rich 
regions, felodipine and mixed felodipine were assigned red, green and blue, 
respectively. For model system II, red was assigned to solid dispersion rich region and 
PVP rich region was assigned blue. With model system III, PVP rich, drug rich and 
solid dispersions rich regions were assigned blue, green and red, respectively. These 
representations were the same both in RGB and scatter plots.
The RGB reconstruction for model system I, II and III are shown in Figure 5.9A, B and 
C, respectively. From the RGB representation for model system I, II and III, the 
composite image derived shows two components, one component and possibly three 
components respectively. However there is no marked discrimination between 
components for model system III within the image.
The scatter plots (image visualisation) for model systems I, II and III are shown in 
Figure 5.10D, E and F, respectively. The loading scatter plot (Figure 5.1 OB) for model 
system II has data points forming a systemic shape in downward direction meaning the 
solid dispersion rich region and PVP rich region form a uniform distribution but are 
anti-correlated to each other. The loading scatter plot (Figures 5.10A and C) for model 
system I and III shows clear discrimination between the components. From the loading 
scatter plot, PRESS plot (Figures 5.3C and 5.7C) and composite images it is evident that 
model systems I&III contain at least three components. That is, model systems I and III 
are phase separated to different degrees, while model system II is homogeneously 
distributed, which agrees well with the data processing results.
Table 5.3 Colour assigned to individual components in composite image
Model System I Model System II Model System III
Red Cinnarizine Rich regions Solid Dispersion Solid Dispersion
Green Felodipine -Not Applicable- Felodipine
Blue Diffused Felodipine PVP PVP
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Although conclusions from the scatter plot are similar to RGB reconstruction, the 
advantages obtained using scatter plot options are multitude. Firstly, with RGB only 
three components can be used while with scatter plot reconstruction at least six 
components can be used. Secondly, the discrimination between various components is 
better in a scatter plot than RGB reconstruction model.
5.7.4 Validation o f  MCR scatter plot
Although multivariate curve resolution extracts spectra from unresolved data, the 
problem of rotational ambiguity within the obtained results is a serious issue.142,144,224,225 
That is, MCR can produce solutions (called principal factors) that fit mathematically, 
but do not carry any physical or chemical meaning and this uncertainty is called 
rotational or intensity ambiguities. In line with this, in order to overcome these issues 
we applied multivariate statistical tools like scatter plot to MCR concentration data and 
this will be discussed in detail comparing the results from three model systems. In 
Section 5.7.2 image visualisation tools, the scatter plot was described. The scatter plot 
can be used to obtain component distribution images, graphical displays o f the variables 
and a means to understand the relationship or correlation between the variables. The 
obtained results are then cross-validated with PCA results.
In this point of view, the MCR concentration images for various model systems were 
plotted as MCR factors vs. pixel response, as shown in Figure 5.11 A. This generates a 
MCR score scatter plot. The generated score scatter plot indicates the relationship 
between the factors. If  the separation between the factors is large it indicates different 
chemical entities. The results indicate that there are three different factors with a cross 
over point signifying there is an interface. The MCR loading scatter plot can be 
generated and interpreted the same way as PCA loading scatter plot (cf. Section 5.7.2). 
When two MCR factors are plotted to understand the correlation between them they 
signify the distribution of the components in the sample. Scatter plot of PF1 
(cinnarizine) vs. PF2 (felodipine) of the model system I, shows clear separation between 
the components and this is cross validated against the PCA scatter plot shown in Model 
system I (Figure 5.1 IB) and Model system II (Figure 5.11C), respectively. The score 
scatter plot, loading scatter plot thus indicate that the model system II is highly phase 
separated.
In this context, the concept o f the aforementioned discussion was extended to model 
system II and model system III where the MCR loading plot results indicate there are
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two and three components respectively. Moreover, the MCR score scatter plot indicates 
homogeneous and heterogeneous distribution, model system IIB and model system IIIB 
respectively. This is in good agreement with the PCA scatter plot results, shown in 
model system IIC and model system IIIC.
These results show that with confidence scatter plots can be applied to estimate the 
number o f components and its distribution in order to avoid ambiguities in MCR results.
5.8 Conclusions
In this chapter, several image processing tools have been evaluated in an attempt to 
better extract distribution maps of various species in the multi-component mixtures. 
Three model systems, that is high, low and medium contrast samples, were included in 
the study. O f the three systems, the number of components and their identity were fully 
known for the high contrast sample or model system I and low contrast sample or model 
system II. Then, the developed data pre-processing and data processing tools were 
extended to the medium contrast sample or model system III whose identity was 
unknown or sparsely known.
Univariate analysis’, for example peak height measurements, is the simplest approach 
used to generate an intensity or distribution map of various components in the mixture. 
That said, it is not always straight forward when systems under study are prone to 
optical artefacts like thickness variations, optical artefacts like scattering and 
importantly when overlapping bands in multi-component mixtures are present. We have 
clearly demonstrated that even with the simplest model system studied, in the absence 
of data pre-processing steps, the results can be very misleading.
Compare Correlation mapping is a useful tool for studying the distribution or 
homogeneity of various components within the multi-component mixtures. In the 
present study, the correlation co-efficient scale was applied successfully to trace the 
distribution of each component and "Histogram" was used to study the uniformity in the 
distribution of components. Since pixel-wise correlation of each component within the 
hypercube was made, this provides an insight into the sample uniformity and this was 
directly related to the number of components present in the sample. However, compare 
correlation was successful only with the low contrast model systems. With the high and 
medium contrast sample it showed poor agreement with the other approaches. Compare 
correlation probably requires additional training data. Furthermore, it also requires prior
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knowledge about the sample which restricts its wide spread application especially in 
stability and degradation studies or reaction monitoring etc.
Composite
Images
Model System I Model System II□Model System III
Figure 5.9. Image Enhancement Tools (RGB Reconstruction)
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D E
Composite
Images
Figure 5.10. Image Enhancement Tools (Scatter Plot)
Principal Component Analysis (PCA) has been demonstrated to be an effective tool to 
study the sample when only an exploratory type of data analysis is required. PCA 
identifies the number of pure components present in the sample without supervision or
without prior information. Mostly, the loading image cannot be a good starting point to 
extract the information about the sample because any principal components (PC’s) do
• 136not necessarily correspond to one specific chemical component in the mixture. 
Instead, in our studies the predicted residual error of sum of squares (PRESS) plot was 
successfully used. Additionally prior knowledge about the sample together with the 
compare correlation results was validated while determining the number of components 
that are expected to be present within the sample. Multivariate curve resolution (MCR) 
extracts straightforward information about the identity and the distribution map of 
‘pure’ components in the mixture. Such resolution methods do not require any prior 
information about the sample and do not suffer from any inteferences.4 Moreover, the 
MCR results are in good agreement with the PCA results.
More detailed analysis has shown that data pre-processing is vital in order to avoid
misinterpretation. Through the application of chemometrics to FTIR chemical images,
226the optical artefacts are separated and chemically significant information is extracted . 
Additionally, a synergistic combination of FTIR imaging and chemometric tools 
unravels the wealth of information contained in the resulting images. Optimised image 
preprocessing, processing and a flow chart of the various steps involved in the 
extraction of information from the mid infrared chemical images are shown in Table 5.4 
and Figure 5.12 respectively.
Table 5.4. Optimised image preprocessing and processing tools
Factors Comments
Sampling Method Depend upon the analysis need
Data Preprocessing
Spikes, Bad Pixels Pixel (NaN) mask
h 2o , c o 2 Truncate data to region of interest (T-ROI)
Baseline correction Second derivative
Thickness variations Peak Height Normalisation
Scattering Truncation
Data Processing MCR/PCA preferred (depends on the need)
Image Visualisation Scatter Plot
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Transmission 
Reflection-A bsorption 
Grazing angle
FTIR Measurement 
GeometryAttenuated Total Reflectance^
Optical artefacts or non- 
linearities
Hypercube Spectral or NaN maskTruncate to regions of 
interest
Second Derivative
Normalisation
processing steps
Image visualisation tools
Figure 5.12. Overview of various steps involved in extracting information from 
mid infrared chemical images
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C h a p t e r  6.
T h e  A p p l ic a t io n  o f  V ib r a t io n a l  Sp e c t r o s c o p y  t o  So l id  
D is p e r s io n s  : F in a l  P r o d u c t  C h a r a c t e r is t ic s
6.1 Introduction
Even though large numbers of studies on spray drying,29,52,227'230 rotary 
evaporation39,61,64,231 or rapid solvent evaporation46,93 are available only a limited 
number of articles are dedicated to study the effect of solvents on the resulting solid 
dispersions. The distribution of various components within the solid dispersions will be 
influenced by the solubility of individual components within the dissolving solution. To 
the best of our knowledge, to date, there has been no work reported describing the 
importance of solvent induced component distribution with respect to preparation of 
solid, dispersions. The goal of this work is to understand the relation between the 
kinetics derived from the bulk spectroscopy studies and microscopic chemical 
characterisation. In this regard, the work described in this Chapter is carried out to 
answer the following questions;
1. Can FTIR imaging be applied to complement the findings of in situ monitoring 
to study the impact of solvent interaction on the distribution of the felodipine 
and PVP within the prepared solid dispersions?
2. Can FTIR imaging be applied to study the phase separation in the resulting solid 
dispersions?
This Chapter is divided into two parts. In order to provide insight into solid-solid 
interactions and its relevance in the formation of intimately mixed solid dispersions, 
firstly, the results from Chapter 4 are further investigated. The bulk spectroscopic 
results (ATR-FTIR measurements) are discussed to understand the drug-polymer 
interactions in detail. Secondly, mid infrared imaging is applied to extract microscopic 
and spatial information on the distribution of various components within the solid 
dispersions. Then the results are combined and correlated to understand the impact of 
adhesive and cohesive interactions on the compositional distribution, hence the phase 
behaviour o f the prepared solid dispersions.
6.2 Experiments
6.2.1 Materials
Materials used are a model drug, felodipine (AstraZeneca, U.K) and the polymer, 
Polyvinylpyrrolidone (Plasdone, K29/32), purchased from International Speciality
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Products (ISP). Acetone, dichloromethane and methanol (HPLC grades) were obtained 
from Sigma-Aldrich, Switzerland. Unless stated, the drug, the polymer and the solvents 
received were used as obtained.
6.2.2 Sample preparation
For ATR-FTIR measurements, three different drug-carrier weight ratios (20:80, 50:50 
and 80:20) for binary systems, 100% drug or 100% polymer and two different mixed 
solvent systems (acetone/methanol and DCM/acetone at 50:50 v/v) were used, lg  of the 
solid was dissolved in 25ml o f the solvents to yield 4 wt% solutions. 50 pi of each 
solution was cast directly onto a pre-heated ATR crystal using a Gilson pipette. Studies 
were carried out at 30°C, 40°G and 50°C respectively. Each experiment was conducted 
with 5 replicates to ensure reproducibility.
For spectroscopic imaging studies, drug-carrier weight ratios for binary systems were 
20% felodipine and 80% PVP which were dissolved in the mixed solvent 
(acetone/methanol and DCM/acetone) systems (50:50% v/v) to yield 4% w/v solution. 
The prepared solutions were spray coated (using a Badger air brush) on to a 316 
stainless steel reflective substrate and stored in the dessicator.
6.2.3 Experimental Parameters
Fourier Transform Infrared spectra were collected using a Specac ATR system attached 
to a Thermo Nicolet Nexus bench equipped with a Mercury-Cadmium-Telluride 
detector. The spectra were collected between 4000-650 cm'1 at a resolution of 4 cm '1 
using 4 co-added scans. The spectra were collected in the series mode (continuous 
collection of spectra over a pre-determined period for 5 minutes), a method available 
within the instrumental software. All the spectra during the kinetic study were collected 
in the Logl/R  format. Background spectra of the clean ATR crystal were collected 
before each sample spectrum.
Chemical Images were obtained using a Varian FTIR Imaging spectrometer in 
reflection-absorption mode. The images were collected between 4000-920 cm '1 at a 
resolution of 4 cm'1 and 64 co-added scans. Data analysis was performed using peak 
height and chemometric approaches (data preprocessing, data processing (MCR-ALS) 
etc) were performed as described in image processing tools (cf. Chapter 5).
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6.3 Results and Discussion
6.3.1 PVP Final Product Characteristics
From the in situ or kinetics of solvent evaporation experimental results (cf. Chapter 4) it 
was evident that the solvents evaporated rapidly and the dry film was formed well within 
100 seconds. So we considered that data studied around 5 minutes is representative of a 
dry film. At this stage, any frequency shifts observed indicates solid-solid interactions.
a. Effect o f  solvents
The final product characteristics are different when PVP is cast from an 
acetone/methanol or DCM/acetone binary solvent mixture as shown in Figure 6.1 and 
Table 6.1. Since, PVP contains tertiary amide it is susceptible to the nature of the 
solvents. 176 When PVP is cast from acetone and methanol the final film is brittle, thin 
and transparent. This is attributable to the conformational changes due to the pyrrolidone 
ring reorientations and FI-bond interactions, hence, increased PVP segmental motion 
when PVP interacts with proton donor systems.232,233 As previously stated, the carbonyl 
peak of PVP undergoes a lower wavenumber shift and appears at 1650 cm '1. Moreover 
the appearance of the 6 (CH2) at 1436 cm ' 1 indicates that the carbonyl environment is 
influenced by molecular interactions234 through the formation of H-bonds. Since there is 
hydrogen bond formation with methanol, there is increased PVP segmental motion.
However, when PVP is cast from DCM/acetone the scenario is quite different (Figure
6.1 and Table 6.1). That is, the final product formed is rubber like, thick and opaque. 
These changes indicate that there is volume and hence the PVP dimension changes and 
assumes a globular structure.235 The carbonyl group in the final product appears at 1664 
cm"1 which indicates that there is increase in the dipolar interactions and increase in the 
rigidity of the pyrrolidone rings which also leads to the formation of the globular 
structure to minimize the contacts between the PVP segments and the solvent 
molecules.235,236
b. Effect o f temperature
As discussed in the previous section, temperature has a marked effect on the kinetics of 
PVP formation and also on the final product characteristics. When PVP is cast from the 
acetone/methanol binary solvent mixture the carbonyl band appears at 1650 cm '1, 1658 
cm' 1 and 1661 cm ' 1 at 30°C, 40°C and 50°C, respectively (Figure 6.2A and Table 6.2). 
These shifts indicate the effect of temperature, that is, as there is increase in the 
temperature, the rate of solvent evaporation is increased thereby decreasing the
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solvation237 and hence the higher wavenumber shift in the carbonyl peak. Moreover, it 
has been shown that methanol is a good solvent for PVP at 25°C, which ties up well with 
our results.238
In comparison, when PVP is cast from DCM/acetone, the carbonyl peak appears around 
1664 cm '1, 1670 cm ' 1 and 1667 cm ' 1 at 30°C, 40°C and 50°C, respectively. This upward 
shifts indicate that there is little or negligible solvation of PVP by this system and hence 
the final product is waxy or globular in structure. It should be noted that, the intensities 
of the PVP carbonyl peak cast from DCM/acetone compared to acetone/methanol 
(Figure 6.2B and Table 6.2) are weak, which means that there is no close contact with 
the crystal or the sample is washed away (also cf. the CH and OH stretching is weak as 
shown in Figure 6.1).
6.3.2 Felodipine final product characteristics
a. Solvent Effects
From the Figure 6.3A, B and Table 6.3, it can be seen that in the starting material of 
felodipine, the NH stretch peak appears around 3363 cm '1. Moreover, the carbonyl 
region has multiple peaks, of which one appears around 1694 cm ' 1 and another around 
1686 cm'1, these being assigned to ethyl ester carbonyl and methyl ester carbonyl 
respectively.
When felodipine was cast from the acetone/methanol binary solvent mixture, the peaks 
broadened and there was an approximately 25 cm ' 1 shift in the NH peak position. 
Simultaneously, there were changes in the carbonyl region in which the ethyl ester 
carbonyl had an 8  cm’ 1 downward shift, whereas the methyl ester carbonyl had a 4 cm ' 1 
upward shift. These results indicate that there is stronger drug-drug intermolecular 
hydrogen bonding when felodipine is cast from solvents, than in the starting material, 
which is a pharmaceutical solid. Moreover, the ethyl ester carbonyl forms a stronger H-
i ncbond than the methyl ester carbonyl.
b. Effect o f temperature
Although temperature is having a marked effect on the kinetics of felodipine film
formation, from Figure 6.4 A, B and Table 6.4, it can be seen that temperature is not
having any marked effect on the final product characteristics. Any change in the
felodipine NH stretching and carbonyl peak positions can be used as a spectral signature
to indicate the effect of temperature. From Figure 6.4A, B and Table 6.4, it can be seen
that the felodipine NH and carbonyl peak position cast from the two different binary
solvent mixture at three different temperature (30°C, 40°C and 50°C) was found to have
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no significant difference on the final product. Marsac et al.*% showed that drug-drug 
intermolecular hydrogen bonding interactions show a gradual and systematic shift in 
peak position from 3337 cm ' 1 at 5°C to 3350 cm' 1 at 160°C. The change in peak position 
versus temperature was dependant on the glass transition temperature of the system 
investigated.8 8 ,175 The Tg of felodipine is 43°C. We might anticipate a shift of ~1.6 cm ' 1 
(based on a 13 cm ' 1 shift over 15°C to 160°C range) and our working spectral resolution 
was 4 cm'1. However, in our studies the spectral changes reported by Marsac were not 
observed because the temperature range studied was narrow and the expected shift was 
smaller than the spectral resolution. This observation is independent of the nature of the 
solvents used for casting felodipine.
c. Effect o f Polymer loading and Drug Loading
The presence of polymer influenced the final product characteristics of felodipine. 
felodipine is a proton donor and interacts with a proton acceptor molecule like 
PVP 11,22,71,86,239 jn absence of polymer, the NH stretching peak appears at 3363 cm ' 1 
or around 3337 cm ' 1 as in the case of starting material or cast film respectively. When 
the polymer is incorporated there is at least a 45 cm ' 1 red shift and the NH stretching 
peak appears around 3292 cm ' 1 in the final product (Figure 6.5 A, B and Table 6.5). This 
clearly illustrates the existence of strong hydrogen bonding between the drug and the 
polymer and indicates the formation of solid dispersions.
When PVP is cast from DCM/acetone the final product formed is rubber like, thick and 
opaque evidenced from the carbonyl group appearing at 1670 cm ' 1 (cf. effect of solvents 
on PVP characteristics, Chapter 4.4.1). The drug loading (20%, 50% and 80% w/w) was 
found to have an effect on the final product characteristics o f polymer when cast from 
DCM/acetone (Figure 6.5 B and Table 6.5). Firstly, the final product formed is brittle, 
transparent and it appeared similar to the final product cast from acetone/methanol 
binary solvent mixture. In the presence of drug, there is appearance of NH stretching 
peak (due to hydrogen bond formation) in the final product (Figure 6.5A and Table 6.5) 
which indicates formation of solid dispersions. The formation of solid dispersion alters 
the final product characteristics of PVP from rubber like to brittle.
The drug loading was found to have a remarkable effect on the intermolecular 
interactions between the drug and the polymer, shown in Figure 6.5 A, B and Table 6.5. 
When the drug loading was low (20% drug loading) the NH stretching peak appeared 
around 3292 cm ' 1 which indicates that there are strong H-bonding interactions between 
the drug and the polymer when compared to cast felodipine or the felodipine starting
106
material. As the drug loading is increased the drug-polymer interactions become 
disrupted and there is increase in drug-drug interactions.240 This was tracked using the 
changes in the peak intensities, peak widths and peaks shifts as shown in Figure 6.5 and 
Table 6.5.
The nature o f  amorphous states depend on the drug-polymer ratio and with low drug 
loading concentrations, the drug-polymer interactions yield stable and miscible solid 
dispersions.50,51,240 As the concentration of drug is increased there is reduction in the 
drug-polymer interactions, potentially leading to physical instability. Although the final 
product characteristics of 20% drug loaded felodipine/PVP solid dispersions cast from 
both the solvents were similar, in order to understand the impact o f solvents on the hase 
behaviour, mid infrared imaging studies will be carried out.
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6.3.3 Spectroscopic Imaging
Felodipine/PVP solid dispersions spray coated from the two binary solvent mixtures 
(optical images) are shown in Figures 6.7A and 6 .8 A. Initially the spectra (from 
chemical images) are monitored for a classical comparison to look for similarity in 
results between the bulk and microscopic evaluations. From the spectra it can be clearly 
seen that irrespective of the solvents (acetone/methanol, Figure 6 .6 A and DCM/acetone 
Figure 6 .6 B) there is strong drug/polymer intermolecular interactions like the presence 
of felodipine (V(co> 1099 cm'1) along with PVP (V(ch) 2885 cm '1) and absence of 
crystalline felodipine peak and will hereafter be termed as "homogeneous 
felodipine/PVP solid dispersion regions".
The spectra from the chemical images of felodipine/PVP solid dispersion cast from 
DCM/acetone sample showed two additional types of distribution. In both types, the 
drug deemed to be amorphous (due to the appearance of NH stretching peak, positioned 
at -3338 cm’1). The appearance of the NH stretching peak, and partially interacting PVP 
(evidenced from the V(ch) 2885 cm'1) is visualised. This will hereafter be termed as 
“polymer rich regions with amorphous felodipine (represented as polymer rich)”. And 
there is also another type of felodipine distribution wherein there is no evidence o f PVP 
bands and this will be thereafter termed as "amorphous felodipine rich region 
(represented as drug rich region)". These initial observations show that the FTIR image 
of the final product differs depending upon the solvent mixture. However, no 
conclusions can be derived on the compositional distribution for the reason discussed 
under Chapter 6  on image processing tools. This is because the raw image data is prone 
to physical artifacts like baseline drifts, saturated/noisy pixels, thickness effects etc. 
Firstly, the data is pre-processed to remove the aforementioned artifacts and then was 
analysed using multivariate curve resolution approach (discussed in Chapter 3.).
Figure 6.9A and Figure 6.9B show the resulting ‘pure component’ factors from the
MCR-ALS analysis compared to ‘real’ pure components. Figure 6.9A shows the
comparison of MCR factor 1 with the second derivative spectrum of pure PVP prepared
from acetone/methanol solution. Strong correlation between the ‘spectra’ can be
observed in the following spectral regions V(ch> 1465-1425 cm '1, V(cNorcc) 1322-1276
cm'1, V(co) 1022 cm'1. Similarly, from Figure 6.9B we can observe that MCR factor 2
has similarities to the pure spectrum of PVP, the pure spectrum of felodipine, but the
greatest correlation to the real pure component spectrum of a felodipine/PVP solid
dispersion. This can be shown by closely looking at the spectral regions corresponding
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to reference felodipine/PVP solid dispersion V(CN,orcc) 1322-1276 cm*1 and V(coc) 1145 
cm'1-! 103 cm ' 1 regions. Thus MCR factor 1 and MCR factor 2 can thus be assigned to 
PVP rich and solid dispersion rich regions, respectively.
The distribution o f the pure component spectra generated from the MCR-ALS analysis 
(i.e. MCR factor 1/PVP rich region and MCR factor 2/solid dispersion rich region) are 
shown in Figure 6.7B and 6.7C. To further substantiate these findings, the results from 
loading scatter plot generated from MCR principal factors (Figure 6.11 A), score scatter 
plot generated from MCR concentration images (Figure 6.1 IB) and image visualisation 
tool (Figure 6.7D) are used. This is because, MCR estimates the concentration of each 
factor or analyte based on pixel to pixel variations. 136 The loading scatter plot of MCR 
factor 1 and 2  describe a negative trend which implies that the two factors show 
negative correlation. Also the score scatter plot of MCR factors vs. pixel response show 
good separation between them (Figure 6.1 IB) which indicates that they are derived 
from separate chemical entities. These two components are identified to be pure PVP 
and solid dispersion (felodipine/PVP) and are merged to a single composite image using 
image visualisation tool and is shown in Figure 6.7D. The PVP rich region is indicated 
in green and solid dispersion rich region is indicated in red. The resulting composite 
image shows that the distribution of solid dispersions is dominant in the chemical image 
and only a few pixels indicate the presence of pure polymer (indicated in green).
When the solid dispersions are cast from acetone/methanol, results from in situ 
measurements indicate that drug does not interact with acetone and neither does 
polymer. The drug and polymer interacts with methanol which correlates well and ties in 
with the imaging results; that felodipine/PVP solid dispersion cast from 
acetone/methanol binary solvent mixture are found to be homogeneously distributed, 
hence relatively low number of pure PVP pixels.
When the felodipine/PVP solid dispersion is prepared from DCM/acetone solution, the 
final product, that is, the compositional distribution of felodipine and PVP are quite 
different. Figure 6.10A, Figure 6.1 OB and Figure 6 .10C show the resulting ‘pure 
component’ factors from the MCR-ALS analysis compared to ‘real’ pure components. 
Figure 6.10A shows the comparison of MCR factor 1 with the second derivative 
spectrum of pure PVP prepared from DCM/acetone solution. Strong correlation 
between the ‘spectra’ can be observed in the following spectral regions V(ch) 1465-1425 
cm'1, V(CNorcc) 1322-1276 cm'1, V(co) 1022 cm '1. From Figure 6.10B we can observe that 
MCR factor 2 has similarities to the pure spectrum of felodipine prepared from
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DCM/acetone in spectral regions corresponding to V(cn,cc) 1506 cm '1, V(coo) 1253-1174 
cm '1, V(coc) 1143-1103 cm ' 1 and V(cc,ch) 1076-1043 cm'1. Similarly MCR factor 3 
shows good correlation to the real pure component spectrum of a reference 
felodipine/PVP solid dispersion. This can be shown by closely looking at the spectral 
regions corresponding to felodipine/PVP solid dispersion V(cn, or cc) 1322-1276 cm' 1 and 
V(coc) 1143 cm'1-! 103 cm' 1 regions. Thus MCR factor 1, MCR factor 2 and MCR factor 
3 can thus be assigned to PVP rich, felodipine rich and solid dispersion rich regions, 
respectively.
The distribution of the pure component spectra of MCR factor 1/PVP rich region, MCR 
factor 2/felodipine rich region and MCR factor 3/solid dispersion rich region generated 
from the MCR-ALS analysis are shown in Figure 6 .8 B, Figure 6 .8 C and Figure 6 .8 D 
respectively. In order to validate these findings, the results from loading scatter plot 
generated from MCR principal factors (Figure 6 .12A), score scatter plot generated from 
MCR concentration images (Figure 6.12B) and image visualisation tool (Figure 6 .8 E) 
are used. The loading scatter plot indicates heterogeneous distribution and score scatter 
displays that these three components are chemically similar. The three components are 
1 . "amorphous felodipine rich region (represented as drug rich region)" 2 . “polymer rich 
regions with amorphous felodipine (represented as polymer rich)” and 3. "homogeneous 
felodipine/PVP solid dispersion regions" (cf. Chapter 6.3.3). These three major 
components were merged to a single composite image using image visualisation tool 
and is shown in Figure 6 .8 E. The PVP rich region is indicated in green, felodipine rich 
regions in blue and solid dispersion rich region is indicated in red. These results indicate 
that there is significant phase separation of drug and polymer.
In considering the mechanism of phase separation, this is better explained when 
considering and combining the results from the in situ measurements of DCM/acetone 
binary solvent mixture. We have already shown that in the DCM/acetone binary solvent 
mixture felodipine interacts with acetone and with dichloromethane. However, PVP 
interacts only with the dichloromethane. Effects o f solvent on the phase behaviour o f the 
polymer blends have been studied and reported extensively within the polymer 
industry.241' 245 When the interaction parameters between the solvent and two miscible 
components are very different, the solvent induces phase separation.246 In DCM/acetone 
the interaction parameters between the solvents, felodipine and PVP are different (cf. 
solvent acceptor number and donor number discussed in Chapter 4). Also the
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conformational states of the polymers vary significantly in solution and this dictates the 
solid-solid miscibility and the drug-polymer interactions.
Mandal and Woo, have discussed in detail the effect of solvents and casting 
temperatures on the phase behaviour of poly (vinyl methyl ether)/poly (benzyl 
methacrylate) . 247 They reported that phase separation can be induced at high 
temperatures between weakly interacting miscible polymer mixtures and poor solvents. 
6.4 Conclusions
Variable temperature ATR-FTIR, Spectroscopic imaging along with chemometric data 
analysis are powerful tools to investigate the molecular interaction and distribution of 
various components within the prepared solid dispersions. Preparation methods and 
solvents can induce phase separation and we have shown the applicability and strength 
of combining bulk and microscopic measurements. Moreover we have shown that 
properly processed and analysed chemical images are invaluable. In most of the 
literature it has been shown that phase separation is generally explained by calculating 
the Tg or dielectric measurements or molecular mobility. In this chapter we have 
presented the novel way for interpreting the drug-polymer or solvent induced drug- 
polymer phase separation.
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Figure 6.6A. Typical spectra extracted from the various regions of Fel/PVP 
prepared from acetone/methanol
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Figure 6.6B. Typical spectra extracted from the various regions of Fel/PVP 
prepared from dcm/acetone
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Figure 6.9B Comparison of MCR factor 2 with spectrum of reference solid 
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C h a p t e r  7. 
In f r a r e d  Im a g in g  in  A s s e s s in g  t h e  T h e r m a l  S t a b il it y  
o f  So l id  D is p e r s io n s
7.1 Introduction
PVP is an extensively used polymer in a variety o f industries. In polymer industries 
degradation studies are important in understanding the properties o f the materials when 
subjected to extensive storage conditions. PVP behaves differently when exposed to
248 248nitrogen, hydrogen or oxygen atmospheres. In situ FTIR measurements were 
successful in showing the degradation of PVP-Rhodium and PVP-Platinum 
nanoparticles. The results indicated that the PVP bound to surface metal ions underwent 
degradation faster than the unbound or outer layer of PVP. Moreover, the 
decomposition of PVP-Pt occurs 100 °C below that of p y p  59>248>249 Two routes of 
oxidative degradation of PVP57 both involving the a-position of N-atom has been 
proposed.57 If  a secondary carbon atom in the pyrrolidone ring is attacked it forms a 
complex (imide) cyclic carbonyl structure (Figure 7.1C) with infrared peak position 
centred around 1772 cm'1. If the tertiary carbon in the back bone is attacked then it 
forms an aliphatic ketone (Figure 7.ID) having a peak at 1729 cm '1. In highly filled 
PVP silica polymeric systems the formation of imide-like structures was hindered due 
to the formation of H-bond between PVP and silica.58
The chloride containing 1,4 dihydropyridine derivatives like felodipine are thermally 
stable to dry air temperature at 90 °C for 120 days;250 however they are very sensitive to 
ionising (beta and gamma) radiations.251,252 When felodipine is heated above its melting 
temperature (145 °C), it forms a (partially) thermally decomposed product. However it
• • 68 253is not found in commercial products like Plendil. ’
When PVP and felodipine are solvent cast, the resulting solid dispersion is stable at 
higher temperatures (160 °C) and cooling to the ambient temperatures shows the 
reversible (in the absence of moisture) nature of H-bond interactions, that is, the drug- 
polymer interactions weaken as the temperature approaches the melting point of the 
drug; subsequent cooling restores the H-bond interactions (which become strong).
FTIR imaging has been applied to study the oxidative degradation of rubber and showed 
that vulcanisation of rubber starts by forming free radicals; however a self protective 
coating is formed to resist the decomposition 254 In a related study addition of 
antioxidants resisted the decomposition in the beginning stage but degradation was
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found to increase as oxygen penetration at later stages aggravates the decomposition of 
rubber.255 The spatial selectivity of FTIR imaging was successful in tracing the 
competitiveness o f the antioxidants and the self protective layer to inhibit the 
oxidation.254,255
The identification of small quantities of degradation products can be difficult to observe 
if there is spectral overlapping or optical artefacts. In these cases, the application of 
chemometric processing tools like multivariate curve resolution (MCR) can be handy 
and serves the required purpose by decomposing pure spectra from the mixtures and 
extracting the corresponding distribution maps. In determining the degradation products 
of nifedipine, MCR was successful in extracting two components from the sample 
matrix, one corresponding to nifedipine and other to the photo-decomposition product 
nitrosopyridine. 137,250
7.2 Objective of the present study
This work aims to investigate the applicability of mid-infrared imaging in generating 
the chemical distribution maps of model components, evidence of thermally induced 
separation and identification of the thermally degraded products from spray coated 
felodipine/PVP solid dispersions.
7.3 Structures of the starting materials and degradation products
.CH,
Figure 7.1. Chemical structures of felodipine (A), PVP (B) and PVP degradation 
products (C, D, E and F)
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Table 7.1. Characteristic peaks of starting material and degradation
products59’68’88’248’249’253
Felodipine (A) PVP (B) PVP Degradation Products
V(NH) 3354 cm ' 1 V(CH) 2873 cm ' 1 C. V(c=o) -1772 cm ' 1
V(C=0) 1700 cm ' 1 V(C=0) 1673 cm ' 1 D. V(c=o) -1729 cm' 1
6 (coc> 1205 cm ' 1 6(CH sci) 1419 cm' 1 E. 6 (c=c) ~802 cm' 1
S(cco) 1095 cm ' 1 6 ( c n  or c h  wag) 1 2 8 0  cm 1 F. 6 ( r c=c ) ~966 cm ' 1
7.4 Experiments
7.4.1 TGA/DTA Measurements
Pure drug and pure polymer were used as obtained (in powder form). A physical 
mixture consisting of 2 0 % drug and 80% polymer (w/w) was made up by physically 
mixing the two components. Another 20% drug loaded sample, prepared in a similar 
manner, was dissolved in mixed solvent (acetone/methanol, %w/v) (FPAM SD) and 
then cast, dried and pulverised. 1 0  mg of the pulverised sample was then placed in an 
alumina crucible. The prepared samples were then analysed using a Netzsch Proteus 
Thermal Analyser under air in dynamic temperature mode. The flow rate of air was set 
to be 40 ml/min. The temperature range set was 25 °C to 800 °C (heating rate of 20 °C 
/min).
7.4.2 In situ FTIR ATR Measurements
50pl o f felodipine (100%) and PVP (100%) solutions prepared using acetone/methanol 
binary solvent mixture were cast onto a preheated ATR diamond crystal at 180 °C and 
the data was collected continuously (as a function of time) for a period of 12h. Thermo 
Nicolet FTIR spectroscopy in attenuated total reflectance (Specac) sampling mode was 
used for data collection with number of scans 64 and spectral resolution o f 4 cm'1. Data 
analysis was done using the Omnic instrument software
7.4.3 Mid infrared imaging
Felodipine-Polyvinylpyrrollidone (Fel/PVP) solid dosage formulations were dissolved
in a methanol/acetone mixture. The prepared solutions were then sprayed using a
Badger air brush on to a 316 stainless steel substrate. The spray coated samples were
stored at different temperatures (room temperature, 60 °C, 100 °C and a temperature of
180 °C, which is above the glass transition temperature (Tg) o f polymer and melting
temperature (Tm) of the drug. The data were pre-processed to remove any optical
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artefacts and data processing done using multivariate approaches (as discussed in 
Chapter 5 image processing tools). All the data analysis was performed using the Isys 
chemical imaging software.
7.5 Results and Discussion
7.5.1 Thermogravimetric/ThermalAnalysis (TG-DTG-DTA) measurements
From the TG curves, the degradation events for pure drug (Figure 7.2A) occur at 240- 
370 °C and 370-600 °C; pure polymer shows different number of degradation events in 
the ranges 300-400 °C, 400-480 °C and 480-660 °C. The differential thermogravimetric 
(DTG) curves (Figure 7.2B) highlight no additional steps are seen to be involved in the 
degradation of either drug/polymer or solid dispersions. The physical mixture and solid 
dispersions shows similar number of degradation events in the ranges 308-371 °C, 375- 
475 °C and 475-600 °C but different trends. The differential thermal analysis (Figure 
7.2C) of pure drug and physical mixture show a transition region centered around 145 
°C which correspond to crystalline melting point of felodipine. However, pure polymer 
and the solid dispersion do not show this transition.
From the TG curve it can be seen that drug on its own begins to degrade at a lower 
temperature than the physical mixture or the solid dispersion, however, polymer on its 
own degrades at the slowest rate. Interestingly, the degradation temperature of physical 
mixture and solid dispersion are found to be similar. However, from the DTA curve it 
can be seen that felodipine is in the crystalline state when in pure form or in a physical 
mixture. However, this peak is absent in the solid dispersion which does mean 
felodipine is in the amorphous form. The initial weight loss around 100 °C is due to loss 
of water.
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Figure. 7.2. TG-DTG (A&B) and DTA (C) measurements
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7 .5.2 In situ A TR-FTIR studies
The spectral changes as a function of time, kinetic profiles for felodipine, PVP and solid 
dispersion are shown in Figures 13 -1 .5 . The infrared spectra (Figure 1 3 A ) at various 
time intervals for the solvent cast film of felodipine at 180 °C together with the kinetic 
profile (Figure 1.5A )  are shown. The chemical structure of felodipine is shown in 
Figure 7.1 A and the major bands of interest in studying the degradation products are 
V(nh> 3354 cm"1, V(c=o) 1700 cm ' 1 and V(c-o) 1095 cm ' 1 shown in Figure 7.3 and Table 
7.1. However, these bands appeared at 3363 cm '1, 1694 cm '1, 1099 cm ' 1 in the 
felodipine starting material and 3337 cm'1, 1699 cm '1, 1099 cm ' 1 in the solvent 
(acetone/methanol) cast film at 30 °C (cf. V ( n h ) ,  V ( c = o ) ,  V ( c - o )  Table 6.4 in Chapter 6 ). The 
amorphous state is thermally unstable.67,256 The NH peak position changes with the 
temperature at 180 °C and this could possibly indicate the weakening of the drug-drug 
intermolecular interactions.88 These changes occur abruptly close to the glass transition 
temperature. The melting point of felodipine68 starting material is 145 °C and the glass 
transition temperature of amorphous felodipine66,256 is ~43 °C. The studied temperature 
is well above the Tg and Tm of felodipine. The observed peak shifts with cast film at 180 
°C indicates the conversion of amorphous felodipine to liquid form or melt. TG-MS 
observations indicated that there is liberation of methylene chloride at -165 °C. The 
change in NH and CO peak positions together with TG-MS results indicate that there 
are small volatile breakdown products like CO2, H2O, CH2CI2, small chain alcohols and 
ketones. The spectral changes of felodipine show no new bands appearing (Figure 
7.5A), thus indicating that there is no formation of new products that remain on the 
surface. These observations illustrate that felodipine oxidises (deduced from the 
disappearance of characteristic felodipine peaks at various time intervals) within 450 
mins, which is expected to happen with small molecules.
The infrared spectrum at various time intervals for the solvent cast film of PVP at 180 
°C and the kinetic profile are shown (Figure 7.4A and Figure 7.5B respectively). From 
the spectral features it can be seen that PVP bands reduce in intensity and also show 
appearance of new bands. The frequencies and structures corresponding to known 
degradation products are shown in Table 7.1C-F and Figure 7.1C-F. The spectral bands 
V ( c h )  2873 cm '1, 6 ( C H Sc i)  1419 cm' 1 and 6 ( C n  o r  c h  w a g )  1280 cm ' 1 are reduced in intensity 
on degradation.58,59,248,249 The observed bands corresponding to degradation products 
are V(c=o> 1772 cm '1, V(c=o) 1729 cm'1, V(c=c)802 cm ' 1 and V(cn-o)9 6 6  cm '1. The V(c=o)
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1772 cm^and V(c=q) 1729 cm' 1 peaks indicate the formation of imides (Figure 7.1C) and 
aliphatic ketones (Figure 7 .ID), respectively.
Interestingly, when felodipine/PVP solid dispersions are subjected to similar conditions, 
the results are quite different. The infrared spectra (Figure 7.3B, 7.4B) and kinetic 
profile (Figure 7.5C) at various time intervals for the solvent cast film of 
PVP+felodipine are shown. That is, the imide band at 1772 cm*1 is of lower intensity 
than the 1729 cm ' 1 aliphatic carbonyl. These observations suggest that intermolecular 
interactions (H-bonding) between felodipine and PVP hinder the rearrangement and 
formation of complex carbonyl-imide like structures.58 There is overlapping or 
contributions from felodipine in the PVP 6 (CHsd) 1419 cm*1 and 6 (CNorCHwag) 1280 cm ' 1 
frequencies. In order to understand whether there is any degradation within the solid 
dispersion, the carbonyl band will be studied initially.
Although there is degradation in the solid dispersion matrix, the felodipine/PVP H-bond 
is quite remarkable in that the drug does not carbonise or evaporate as with the cast pure 
felodipine. Studies have shown that in the absence of moisture when the felodipine/PVP 
solid dispersions are subjected to a temperature rise from 0 °C to 160 °C and subsequent 
cooling, there is a reversible strengthening of the H-bonding interactions.88
Having established some aspects of degradation conditions, we will now further to 
assess the applicability of FTIR imaging to complex systems and then focus on using 
chemometrics to extract the required information.
7.5.3 M id infrared imaging
FTIR imaging is a relatively new technique which provides spectral and spatial 
information for microscopic chemical characterisations. In this study, FTIR imaging 
was used to determine the distribution of the model drug felodipine, the model polymer 
PVP, degradation products or thermally induced phase separation from the prepared 
solid dispersions.
Spray dried samples were stored at 60 °C (temperature above the Tg of drug), 100 °C 
(temperature below the Tg of drug/polymer mixture) and 180 °C (temperature above the 
melting point of drug and Tg o f Polymer). Then the samples were studied as prepared, 
after 1 day, after 1 week, after 2 weeks and after 3 weeks. The emergence of a peak at 
1772 cm ' 1 (ellipse as shown in Figure 7.6) is indicative of the degradation product 
(Figure 7.1C). This indicates the formation of a complex cyclic structure involving a 
carbonyl group. The distribution of the degraded product was generated by plotting the
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intensity of the discrete peak at 1772 cm"1; The successive images shown at 100 °C and 
60 °C are obtained at similar regions in the sample. However, the use of peak height 
tools to extract information from the raw intensity images should be cautiously used. 
This is because the raw hyperspectral data from the reflection measurements are prone 
to optical artefacts.212' 214
Studies from in situ FTIR and TG measurements revealed that any degradation product 
within the solid dispersion is to be expected from the polymer. Moreover, the 
degradation of polymer is a quite complex process wherein the backbone and the 
pyrrolidone carbonyl are involved. In the previous Chapters 5 and 6 , the regions of 
interest for chemometric data analysis for many reasons were restricted to drug bands. 
However, the preliminary measurements here have shown that the degradation is mostly 
associated with the polymer; hence in this study a wider region of interest (1520 to 920 
cm'1) will be used for chemometrics processing. In order to study the applicability of 
FTIR imaging and chemometrics in tracing the degradation products, the samples stored 
at 180 °C (shown in Figure 7.6) was further assessed.
MCR data analysis was done based on hard or white modelling approach, that is, 
sample chemistry, information from TG-DTA and in situ FTIR analysis was used to 
predict the number of chemical components present in the acquired image. A model 
constructed with three MCR factors was used. The pre-processed and processed MCR 
concentration images (cf. Chapter 5 Image processing tools) are shown in Figure 7.7 
(bottom). The extracted spectrum was compared with pure component spectrum of 
'solid dispersion and PVP' as described in Chapters 5 and 6 . Since we did not have the 
pure spectrum of the PVP degradation products, the idea o f cautiously cross-referencing 
the univariate distribution images (Figure 7.7 top) with MCR concentration images 
were used in this study. Moreover, the spectrum of pseudo degradation product 
represented in purple colour (Figure 7.8 A) was obtained from the in situ thermal 
stability measurements. This was created by subtracting the spectrum at time ‘O’ which 
is a non-degraded sample from the final spectrum at time 720 min which was a 
degraded product. These assumptions were made by carefully assessing the infrared 
spectrum at various regions avoiding obvious spectral artefacts.
The distribution image of MCR factor 1 (Figure 7.7) was found to resemble univariate 
image generated using discrete peaks at 1048 cm '1. Figure 7.8 A shows the comparison 
of MCR 'extracted' spectra (MCR factor I) with second derivative spectrum of pure PVP 
and pseudo degradation product spectrum. Strong correlation between the extracted
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spectrum and pseudo degradation product spectrum is interpreted in the following 
regions 1502 cm '1, 1428 cm ' 1 and V(co> 1060-1040 cm '1. Similarity between the MCR 
factor 1 and pure PVP spectrum was observed in v (Ch ) 1297 cm '1. Furthermore, in 
Section 7.5.2 in situ stability studies we showed that PVP on its own degrades to form 
new products on long exposure to higher temperatures. These interpretations show that 
the MCR factor 1 can be assigned to a distribution image of PVP degradation product.
The MCR concentration image 2 (Figure 7.7) was found to resemble univariate image 
generated using discrete peaks at 1099 cm'1. Figure 7.8 B shows the comparison of MCR 
'extracted' spectra (MCR factor 2) with second derivative spectrum of solid dispersion. 
Strong correlation between the extracted spectrum and solid dispersion spectrum was 
observed in the following regions V(ch) 1465-1425 cm ' 1 and V(co) 1103 cm'1. These 
regions are spectral signatures for polymer and drug. Furthermore in Section 7.5.2 in 
situ ATR-FTIR studies showed that drug on its own oxidatively degrades over time; 
however when the drug is dispersed in the polymer matrix as solid dispersion the 
carbonisation is prevented. These interpretations show that the MCR factor 2 can be 
assigned to a distribution image o f solid dispersion.
The concentration image of MCR factor 3 (Figure 7.7) was found to resemble univariate 
image generated using discrete peaks at 1373 cm’1. Figure 7.8C shows the comparison 
of MCR 'extracted' spectra with second derivative spectrum of 'real' component 
spectrum of PVP. Strong correlation between the extracted spectrum and solid 
dispersion spectrum was observed in the following region V(ch) 1525-1425 cm’1. These 
interpretations show that the MCR factor 3 can be assigned to a distribution image of 
pure PVP.
The results indicate that long exposures of solid dispersions to high temperatures induce 
degradation. Interestingly, the drug on its own evaporates at higher temperatures, 
although in the solid dispersions there are drug rich regions. These two components 
were homogenously distributed when stored at room temperature (Chapter 6  on final 
product characteristics). From univariate imaging analysis it is seen that the samples 
stored at the highest temperature showed evidence of rapid degradation, whereas the 
degradation was slower with the samples stored at 100 °C and slowest for 60 °C. 
Unsurprisingly, the samples stored at room temperature showed no degradation.
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Figure. 7.5 In  situ FTIR studies at 180 °C; Felodipine solvent cast film 
(A), PVP cast film (B) and Fel/PVP solid dispersions (C)
133
However, to investigate temperature induced phase separation, the influence of 
temperature on the degradation rate or film thickness we need additional pre-processed 
samples with regions contributing to H-bond or felodipine/PVP interactions etc. This is 
because, in samples containing unknown degradation products, the idea of extrapolating 
already interpreted results will not be an ideal approach. This study shows that 
truncating the spectral bands to regions of interest should be applied cautiously and 
prior knowledge about the materials included in the study is essential. Future work will 
be directed towards inclusion of the carbonyl, and pyrrolidone degradation groups or 
using the entire spectral range and applying other pre-processing steps like mean centre, 
vector normalisation etc in order to effectively interpret the results of the thermal 
stability studies of solid dispersions. Moreover, the in situ FTIR data (Figure 8.5B) 
seems reasonable to fit first order kinetics. Hence future work can be directed to extract 
kinetic information from these measurements.
7.6 Conclusion
Chemical imaging is an effective tool in probing the identification and distribution of 
the degradation products within the solid dispersions. Spectroscopic imaging in 
combination with complementary techniques is an effective tool to better understand 
and locate the degradation products on a micron scale. TGA results revealed that drug, 
polymer and drug/polymer mixture did not show any indication of degradation until 240 
°C. However, in situ FTIR spectroscopy and long-term FTIR imaging results suggest 
that prolonged exposures to dry air induce degradation even at lower temperatures (in 
our studies it is 60 °C). FTIR Imaging facilitates the successful identification and 
distribution of degraded products. The samples stored at 180 °C degraded rapidly, 
whereas the degradation was slower at 100 °C and slowest at 60 °C. Although, the 
selected conditions are extreme ones, the results provide valuable information about the 
storage conditions and their importance.
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degradation products
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C h a p t e r  8. 
S u m m a r y  a n d  C o n c l u s io n s
8.1 Introduction
The aim of the present thesis was to provide working protocols to better characterise the 
morphology, distribution and formation of solid dispersions. The following problematic 
have driven this thesis
A) The application of vibrational spectroscopy to understand the dynamics involved 
in the formation of solid dispersions.
B) Evaluation and optimisation of experimental toolbox for analysing the acquired 
mid infrared chemical images.
C) Further work involving FTIR-Reflection Absorption imaging to better understand 
the potential scope and applications of these techniques in a wider context in 
determining phase separation, phase transition or phase transformation.
8.2 Bulk Spectroscopic Measurements
We have successfully developed a characterisation protocol wherein it is practically 
possible to monitor the formation of solid dispersions in situ using ATR-FTIR 
spectroscopy. To achieve our motivation we selected two different binary solvent 
mixtures (acetone/methanol, DCM/acetone), model drug-felodipine, model polymer- 
polyvinyl pyrrolidone, three different drug/polymer (20% w/w, 50% w/w and 80% w/w) 
ratios and different temperatures (30°C, 40°C and 50°C). Initially, changes in the peak 
positions and intensities were used to follow the kinetics of solvent evaporation and 
solid dispersion formation using t\§ measurements. The Ao kinetic results were obtained 
using peak height measurements and chemometric (multivariate curve resolution) tools. 
There were significant differences only with the t\o methanol results. As a result, 
statistical analysis was carried out to better understand the kinetic results at a 95% 
confidence interval. We showed that MCR is a valuable tool to extract kinetic 
information from complex multi-component systems with overlapping spectral 
signatures.
Moreover, peak position changes, peak widths and intensities were simultaneously 
studied to provide insight into solvent-solvent, solvent solid and solid-solid molecular 
interactions. Finally, we studied the impact of solvent nature, temperature, polymer and 
drug loading on the final product characteristics like drug-polymer H-bond interactions,
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drug-polymer miscibility, distribution and phase separation. Furthermore, interplay 
between t\o, molecular interactions and final production characteristics were studied.
The large scale application of solvent method is spray drying wherein the temperature is 
used as a secondary drying parameter. In this study, the temperature was used as a 
variable to study its impact on solvent evaporation rate/drying kinetics, molecular 
interactions and resultant final (solid dispersion) product characteristics. An increase in 
temperature increased the rate of evaporation of the solvents and did disrupt the solvent- 
solvent and solvent-solid interactions and ultimately the final product characteristics of 
PVP. However, the temperature was found to have no impact on the felodipine and 20% 
drug loaded felodipine/PVP solid dispersions. Higher drug loaded samples behave 
similarly to sample containing drug alone; hence interest was focussed in the low drug 
loaded solid dispersions only.
The selection of solvent or nature of the solvents was found to have a significant 
influence on the drying rate and molecular interactions. That is, acetone evaporated 
rapidly and was found not to interact with the solids in the acetone/methanol binary 
solvent mixture (BSM). However, we showed that methanol interacts with acetone, 
felodipine and PVP through the formation of hydrogen bonds. In order to confirm these 
findings a second binary solvent mixture comprising DCM/acetone was employed. 
Acetone was found to interact with felodipine (H-bond) but not with PVP (nonsolvent 
for PVP). However, DCM interacts with felodipine (H-bond interaction), with acetone 
and PVP (dipolar interactions). There were no significant differences observed in the 
bulk spectroscopic measurements. Interestingly, the results from spectroscopic imaging 
measurements showed that the distribution of various components within the solid 
dispersions was influenced. That is, when felodipine/PVP was cast from 
acetone/methanol the final product was homogeneously distributed, however there was 
phase separation when felodipine/PVP was cast from DCM/acetone. These results 
indicate that the nature of solvents play a vital role in the formation of solid dispersions.
The selection of solvents, temperature and drug loading, as mentioned, was found to 
influence the final product characteristics. The final product is brittle when cast from 
acetone/methanol at 30°C with a low drug loading of 20%. Conversely, PVP is globular 
when cast from DCM/acetone at 30°C with 0% drug loading. Felodipine final product 
characteristics were influenced by the solvent and polymer when compared to starting 
material. However there were no significant differences between two solvents 
(acetone/methanol or DCM/acetone) and various temperatures included in the study.
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It was shown that the solvent nature and temperature played a crucial role in the kinetics 
o f solvent evaporation. Whereas the solvent nature, temperature and solid loading 
protonation of solids, conformational changes in polymer etc.
8.3 Chemical Imaging Measurements
Chemical imaging or spectroscopic imaging systems and their potential applications in 
diverse fields became possible after the introduction o f second generation focal plane 
array (FPA) detectors. However, pharmaceutical applications involving reflection- 
absorption FTIR imaging was scarce. The reasons were lack of basic understanding of 
the acquired hyperspectral data. In this context, we have developed a “bottom-up” 
approach to address the prospective applications of FTIR imaging measurements to 
study the pharmaceutical materials of interest. Firstly, we demonstrated the possible 
reasons for the introduction of optical non-linearities that can influence the acquired 
chemical images. Then data preprocessing steps were applied to remove the optical 
artefacts. In order to extract the distribution maps of various ingredients within the solid 
dispersions different data processing steps were applied. Finally, to understand the 
distribution maps clearly and effectively data visualisation/image enhancement tools 
were carried out.
To achieve our motivation, three different model systems of known composition were 
selected and studied. These model systems were used to demonstrate the efficiency of 
chemometric methods. Then data processing procedures like peak height measurements, 
compare correlation, principal component analysis and multivariate curve resolution 
were applied. The results indicated that model system I was phase separated, model 
system II was homogeneously distributed. The composition for model system I and 
model system II are fully known. Then these procedures were extended to model system 
III whose compositional distribution of components was unknown.
Peak Height Measurement is the simplest approach used to generate an intensity map. 
However, it is not straight forward if physical effects, optical artefacts and overlapping 
bands are present. Compare correlation requires library of pure components sometimes 
which is not possible. Principal component analysis identifies number o f pure 
components present without supervision. However, obtained results cannot be directly 
compared to the pure spectra. In contrast, multivariate curve resolution extracts the 
identity and the distribution map of components that can be directly compared with the 
pure spectra. Moreover, it does not require any prior information about the sample and 
does not suffer from any interference. Finally, we showed that data visualisation
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involving scatter plot provided better means to understand the complex data. Detailed 
analysis has shown that data pre-processing is vital in order to avoid misinterpretation.
Further work was carried out with the aim of understanding the scope of the mid 
infrared imaging techniques in a wider context. Firstly, we studied the solvent induced 
phase separation by casting felodipine/PVP solid dispersion from binary solvent 
mixtures o f varying affinity to felodipine and PVP. In this study we showed that when 
interaction parameters between the solvent and two miscible components are different 
as with DCM/acetone, the solvent induces phase separation. This was successfully 
studied using FTIR imaging technique. Secondly we stored the felodipine/PVP spray 
coated solid dispersion from DCM/acetone in dessicator containing 95% moisture. After 
12 hours the sample was studied using FTIR imaging and the acquired image was 
processed. The results indicated there is significant evidences for moisture induced 
phase transformation of felodipine from amorphous form to its crystalline form. Finally, 
felodipine/PVP solid dispersion was placed at different temperatures (60°C, 100°C and 
180°C) to study the temperature induced phase separation and degradation. We showed 
that the mid infrared imaging was successful in extracting even minute quantities of 
degradation product,
The aforementioned studies show this thesis demonstrates the usefulness of mid infrared 
chemical imaging as a potentially useful tool to study the pharmaceutical materials 
based on the data mining procedures. However, the challenges still remaining with data 
extraction procedures (as shown by studying the degradation products) which will most 
probably continue to be one of the exciting areas of research.
8.4 Complementary techniques -  TG-MS and TG-DTA
TG-MS was successfully used to understand the residual solvent to assist with the 
interpretation of tw measurements, molecular interaction between drug and polymer, 
etc. With TG-MS measurements, it was found that the residual solvents within the 
studied systems (binary solvent mixture, 1 0 0 % polymer and 1 0 0 % drug loaded 
samples) were less than 1 0 % which is accounted in our fio measurements.
Moreover, TG-DTA was used to study and understand the degradation behaviour of 
drug alone, polymer alone, physical mixture of drug and polymer and finally solid 
dispersions. DTA results indicated that drug was in crystalline form in the starting 
material and physical mixture however in amorphous form when mixed with polymer as 
solid dispersion. TGA results revealed that drug, polymer and drug/polymer mixture did
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not show any indication of degradation until 240°C when heated at 20°C/min, but the 
onset of degradation of drug in solid dispersion and physical mixture occurred at a 
higher temperature (~300°C) when compared to drug alone which ties well with, in situ 
studies.
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C h a p t e r  9. 
F u r t h e r  w o r k
9.1 Kinetics of solvent evaporation and drying
The protocols presented here (Chapter 4 and Chapter 6 ) considered the model drug- 
felodipine which is a proton donor and a model polymer polyvinyl pyrrolidone. In order 
to gain a better insight on kinetics of drying and final product characteristics various 
aspects like model drug selection, model polymer selection, solvent selection and drug 
loading can be explored further.
For example, model drugs like griseofulvin (proton acceptor), Cinnarizine (dipole 
interactions), adamantane (neutral molecule) and other polymers like poly ethylene 
glycols, poly methacrylates, cellulose derivatives (hydroxyl propyl methyl cellulose, 
hydroxyl propyl cellulose), starch derivatives (cyclodextrins) etc. Moreover, drug 
loading selected here was to understand the amorphous product formation. In the 
pharmaceutical industry, the solid-solid compositional miscibility of drug in polymer is 
practically more relevant than the polymer in the drug. Also when the drug loading is 
higher than the miscibility composition, the prepared system tends to phase separate. 
The miscible drug loading of felodipine in PVP is 5-25% and its influence on the t\o 
measurements, molecular interactions with solvents and polymer can be studied in more 
detail. One other interesting area is to study the influence of solvent selection especially 
DCM/ethanol which is a widely used binary mixture solvent in preparing solid 
dispersions. When miscible solids interact with both solvents there are more chances 
that solvent will alter the phase behavior. Future work can also involve a systematic 
approach to calculate activation energy (Ea) and/or heats of vaporization which will be a 
useful approach to predict the rate of evaporation of solvents at any given temperature
9.2 Evaluation of image processing tools
In Chapter 5, three model systems of varying chemical composition were selected to 
optimize the data preprocessing, data processing and data post-processing procedures. 
The data pretreatment procedures comprised: selection of a narrow wavenumber region, 
Not-a-Number (NaN) masking, Savitsky-Golay second derivative and peak height 
normalization. The extraction of distribution maps was better explained using 
multivariate curve resolution or principal component analysis. Scatter plot was found to 
be very useful in visual interpretation of complex mixtures.
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The optimized imaging analysis was successful in tracing the solvent induced phase 
separation and moisture induced phase transformation. However, the optimized methods 
were unsuccessful in extracting or tracing entire range of degraded products. With 
complementary characterizing techniques like TGA and in situ ATR-FTIR spectroscopy 
we showed that both carbonyl regions and CH regions were involved in degradation. 
Hence the future studies should involve alternative preprocessing steps like mean 
centre, standard normal variate or vector normalization etc. Also preprocessing different 
wavenumber regions (carbonyl, CH, ester etc) and design methodologies to combine the 
treated data to process the chemical images will be extremely useful to identify the 
degradation products.
9.3 Spectroscopic imaging to determine the final product 
characteristics
The distribution and association of the various components of solid dispersions may be 
critical to the product performance, for example physical stability, dissolution, 
bioavailability etc. In this perspective selection of different model drugs, solvent, model 
polymer etc. and their influence on the dissolution, stability, phase transformation or 
phase separation will be an attractive area of research. Moreover studies can involve by 
selecting a class of model drugs with varying strengths of intermolecular interactions 
with the selected model polymer and study their influence on distribution, storage 
stability, dissolution behavior etc.
In order to provide insight into the phase behavior, for example, moisture induced phase 
separation or phase transformation for the selected model systems, a range of relative 
humidities like 0%-95% at fixed temperature range can be studied. An investigation into 
the possibilities of imaging morphological features such as spherullite structure within 
the phase transformed samples will be an exciting area to understanding the scope of 
mid-infrared imaging techniques in a wider context.
9.4 Stability studies of solid dispersions
The thermal stability of solid dispersions is attributed to various intermolecular 
interactions like hydrogen bonding, Van der Waals interactions etc. The results from the 
degradation studies (cf. Chapter 7.5.2) showed that H-bonding interactions between 
felodipine and PVP inhibited the formation of imide like structures. Hence selection of 
interacting and non-interacting PVP/drug systems to understand the capability of mid 
infrared imaging in assessing the degradation products will be an interesting area of
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research. A related area of interest is the investigation of degradation of solid dispersion 
systems by other types of stresses like Gamma or X-ray radiations and study the 
applicability of FTIR imaging in tracing the degradation products.
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